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Abstract
Numerous diseases affecting living beings have as a cause a modiﬁcation of gene expression
resulting in anomalous expression of proteins in up- or down-regulated fashion, with altered
functions or expression of proteins that are not present in the cell in a normal situation. Among
the well-known examples is cancer, where a series of DNA damages turn cells out of control of
the rest of the body, from which they do not receive or follow control signals. To have a better
understanding of the mechanism of these diseases, in particular the genetic diversity existing
in a single affected tissue, it is necessary to be able to perform single-cell analyses that unveil
the subpopulations of diseased cells leading to adequate medical treatment.
In the course of this thesis, we report on the development of single-cell analysis methods
which are of interest for medical applications. The ﬁrst part focuses on the investigation of
the viscoelastic properties of cell membranes by observing the back-relaxation of plasma
membrane nanotubes which have been pulled out of a cell by an optical tweezer. Applied to
the investigation of the viscoelastic properties of individual tumor cells taken from patients,
we could show that this method can distinguish the state of progress of skin melanoma.
In the second part, we used beads comprising a chemically modiﬁed surface to capture
speciﬁcally one or several proteins inside single-cells. After extraction out of the cell, the
afﬁnity bead is transferred in a microﬂuidic stream of a ﬂuorescently labeled antibody to
detect and quantify the protein(s) of interest. The extraction and detection procedures occur
inside a microﬂuidic platform to allow future automatization of the process.
The last chapter focuses on the use of cell-derived extracellular vesicles (EVs) as diagnostic
and therapeutic agents. With this goal in mind, we explore the potential of EVs as carriers
to transfer genetic material into cells. To demonstrate the feasibility of this approach, we
encapsulate EVs inside a giant unilamellar vesicle and release their cargo in a time- and space-
controlled manner. This method could have therapeutic applications using a patient’s self-EVs
for gene therapy.
Key words: Single-cell analysis, microﬂuidics, optical tweezers, functionalized micro-beads,
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cellular vesicles, lipid vesicles, nanocontainers
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Résumé
Nombres d’affections dont souffrent les êtres vivants ont pour origine une modiﬁcation de
l’expression des gènes résultant en une production anormale de protéines en trop grand ou
trop petit nombre, en des protéines avec une fonction altérée, ou l’expression d’un certain
type de protéines dans une cellule qui en temps normal n’en a ni besoin, ni usage. Parmi les
exemples les plus connus de ce type de maladies, on trouve le cancer, où une série de dégâts
causés à l’ADN perturbe les mécanismes biologiques des cellules qui commencent alors à se
multiplier sans plus recevoir ou suivre les signaux du reste du corps. Aﬁn d’améliorer notre
compréhension desmécanismes de cesmaladies, en particulier la diversité génétique présente
au sein d’un tissu affecté, il est nécessaire de pouvoir effectuer des analyses cellule-par-cellule
permettant de mettre à jour les sous-populations composant le tissu malade, permettant ainsi
un traitement médical adéquat.
Dans cette thèse, nous posons les bases de méthodes d’analyses cellule par cellule promet-
teuses pour des applications biomédicales. La première partie se concentre sur l’analyse des
propriétés visco-élastiques de cellules en observant la relaxation de nanotubes de membrane
plasmique tirés par la force d’une pince optique. Il est ainsi possible de déterminer l’état
d’avancement moléculaire d’un mélanome humain grâce à un petit nombre de cellules exami-
nées individuellement.
Dans la seconde partie nous avons utilisé des billes dont la surface est chimiquement modiﬁée
pour capturer de manière spéciﬁque une ou plusieurs protéines à l’intérieur d’une cellule.
Après son extraction hors de la cellule, la bille est mise en suspension dans un ﬂux liquide
contenant un anticorps ﬂuorescent qui permet de détecter et quantiﬁer la ou les protéine(s)
recherchée(s). L’extraction et la détection ont lieu à l’intérieur d’une plateforme de micoﬂui-
dique de manière à permettre une future automatisation du procédé.
Le dernier chapitre se concentre sur l’utilisation de vésicules extracellulaires (EVs) comme po-
tentiels agents thérapeutiques et outils de diagnostique. Avec cette idée en tête, nous explorons
la possibilité d’utiliser les EVs comme transporteurs de matériel génétique dans des cellules vi-
v
vantes. Pour démontrer la faisabilité de cette approche, nous choisissons d’encapsuler des EVs
dans des vésicules géantes unilamellaires pour pouvoir les relâcher au moment et à l’endroit
souhaité. Le développement de cette méthode permettrait d’agir dans un but thérapeutique
en utilisant les EVs provenant du patient lui-même à des ﬁns de thérapie génique.
Mots clefs : analyse de cellule unique, microﬂuidique, pince optique, micro-billes fonctionali-
sées, cytométrie chimique, microscopie de ﬂuorescence, membranes lipidiques, membranes
plasmiques, vésicules extracellulaires, vésicules lipidiques, nanocontainers
vi
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1 Introduction
1.1 Measuring at the single-cell level - Motivation of the thesis
This thesis concerns the development of miniaturized analytical methods to characterize
biochemical and biophysical properties of single cells in the micrometer and nanometer range
for biomedical diagnostics. To demonstrate the applicability of our bioanalytical tools, we
will primarily focus on tumor cells, which show deeply modiﬁed cellular characteristics, such
as mechanical properties, gene expression, or cellular signaling cascades; however, out tools
are not limited to cancer, but might be of interest for diagnosis of many other diseases which
are modifying cellular characteristics, such as chronic inﬂammatory diseases or viral infec-
tions to mention a few. The ﬁrst part focusses on the development of methods to probe the
viscoelastic properties of cellular plasma membranes and how diseases like cancer can modify
the properties of plasma membranes. The second part focusses on the methods to investigate
molecular composition of individual cells, especially cytoplasmic proteins; as many diseases
affect the production of cellular components, we developed a method to quantify cytoplasmic
proteins using micron-sized afﬁnity beads, keeping a single-cell resolution. The third part
is dedicated to the use of extracellular vesicles as a carrier for genetic material for potential
applications in gene therapy, supplying cells with missing/mistranslated genetic material or
silencing undesirable mRNA.
In the context of deﬁning the general objectives of this thesis, we give in the following para-
graphs (i) a brief outline why single-cell experiments deliver important novel information
on the function of biological cells which cannot be obtained from ensemble measurements
and therefore are of utmost interest for fundamental biological research and biomedical ap-
plications, and (ii) an overview of presently available single-cell technologies which are of
1
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relevance for the present thesis.
1.1.1 Why single-cell experiments
Discovered at the end of the XVIIth century, the biological cell is considered since the middle
of the XIXth century being the constitutive unit of every living being having ever existed on the
planet Earth.[1] The very structure of a cell is deﬁned by its plasma membrane isolating the
cytoplasm from the outside environment. Major cellular components are DNA, RNA, proteins
and lipids. The local concentrations and interactions of these components over time describe
the dynamic biochemical network of a cell. The determination of this networks remains a
challenge, but it would eventually be essential to understand the function or dysfunction of
a living cell in its full complexity.[2] The diverse activities performed by proteins result from
millions of years of evolutionary selection to optimize function, efﬁciency and synergy to
make the organism as competitive as possible inside its environmental context. Changes in
protein synthesis based on genetic or post-translational modiﬁcations lead to substantial
changes of protein function and may turn into diseases.[3, 4, 5] Determination of tissue-
speciﬁc composition (concentration and sequence/modiﬁcations) of the proteome delivers
utmost important information about the condition of a human being with respect to potential
development of diseases.
The characterization of a cell’s proteome, the proteins expressed in a cell, is a bioanalytical ﬁeld
that contributes to a better understanding of cellular functions on a molecular basis.[6, 7] The
proteome of a diseased cell can be quite different from that of a healthy cell, notably in the case
of cancer, viral infections or inﬂammatory diseases.[8, 9, 10, 11, 12] Many diagnostic methods
are focussing on the detection of abnormally expressed proteins, often referred to as pathology
markers, to determine if a person is suffering from a speciﬁc disease.[13, 14, 15, 16] These
methods often rely on a "cell extract" containing components that were constituting particular
cells and are able to exhibit the presence of a speciﬁc marker after a step of concentration,
tagging, conﬁnement or a chemical reaction. Usually many cells are required for analysing the
cellular content; the information obtained is consequently an average value over the number
of cells constituting the sample under investigation.
As tissues are composed of an assembly of different types of cells, the principle of using an
average extract of all these cells as a reference to judge whether the tissue is healthy or not and
from which disorders it suffers, appears to be a poorly precise mode of investigation, unless
2
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the illness has grown to remarkable extent. To circumvent the issues of averaging ensemble
measurements, single-cell analyses have been developed.[17] Single-cell measurements de-
liver actual data of an analyte of interest for each and every cell of a given tissue sample. The
global, average result stays invariant, but the detailed data provide much more information
about the distribution of the different phenotypes. It also provides the possibility to ﬁnd in a
cell population rare cells that could be of a great functional importance, such as stem cells or
rare sick cells.[18, 19] Indeed, the averaged signal hides the contribution of the diverse types
of signals, which could have a strong biological relevance.[20, 21]
Figure 1.1: Schematic comparison between an ensemble and a single-particle measure-
ment. Shown is an ensemble of three different sorts of particles distinguished by color. Single-
particle analysis would distinguish the three sorts of particles and count them individually. An
ensemble measurement on the other hand would detect only the average properties, here the
average color, of the ensemble of particles and thus hide the fact that they are actually composed
of different sorts.
Diseases such as cancer strongly rely on single-cell analysis to understand their character-
istics. As explained in section 1.4, cancer progresses with sequential DNA mutations that
increase progressively the disease’s malignancy. A speciﬁc mutation occurs in one single cell,
which then proliferates to form a new population, eventually overwhelming less malignant
3
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previous populations. Detecting new mutations at an early stage requires the capability of
detecting a speciﬁc phenotype or genotype in a small subpopulation of cells hidden among
a large population. If bulk methods would engulf low frequency signals into measurement
noise or misinterpretation, single-cell techniques leave no doubt about their existence. Cells
propagating metastases, so-called cancer stem cells, are highly malignant tumor cells that
circulate in blood or lymph and, once ﬁxed to a suitable location, seed the initial tumor to
another niche in the patient’s body. Detection of these cells in a blood or lymph stream may
be difﬁcult due to the large number of other cells present in body ﬂuids. Single-cell methods
are the most suitable techniques for this operation, as cancer cells differ signiﬁcantly by their
atypical phenotype and mutated genotype.
Prior to analysis itself, samples must be correctly selected. If biopsies remain the most evident
way of collecting targeted cells, it remains, in some cases, a challenge, if not simply impossible.
Various methods are being developed to render the collection of cells of interest easier for
the medical staff as well as for the patients. As an example, we will brieﬂy go through a few
of them directed towards circulating tumor cells (CTC) which are cells detached from their
tumor of origin and circulating in suspension in blood or lymph. The challenge consists of
ﬁnding these cells present in a very low concentration in blood, among millions of blood cells,
and then to characterize them in order to understand as much as possible the characteristics
of the mother tumor.
Cell Search is a method that allows a reliable detection of the CTC.[22] Ferromagnetic
nanoparticles coated with antibodies recognizing epithelial adhesion molecules are used
to enrich CTCs and to analyze them. Antibodies conjugated to a red dye and directed to
biomarkers of the tumor, in this case cytokeratin proteins, are introduced in the cells of the
enriched sample sample, together with a cell nucleus dye and and a blue dye-conjugated
antibody against a white blood cell speciﬁc protein, after cell permeabilization. After multiple
automated washing steps and magnetic separation, cells containing both the red dye and the
nuclear stainer are recognized as circulatory tumor cells.
1.1.2 Presently used methods for single-cell analysis
The “CTC-chip” captures circulating tumor cells inside a microﬂuidic chip using multiple
PDMS structures coated with anti-epithelial antibodies.[23] At a ﬂow rate up to 2 ml/hr, the
cells have an optimal speed to be in close contact with the surface of cylinders to which the
antibodies are attached. CTC remain attached to the cylinders whereas all other blood cells
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simply ﬂow through the chip. An enrichment surface of 920 mm2 comprising 78,000 polymer
cylinders is optimal for the enrichment of CTCs from blood volumes of several milliliters. CTCs
attached to the microstructures are then ready for subsequent analyses, for example, using im-
munostaining. This isolation procedure has been further enhanced with the implementation
of microvortices, using a two-level micro-patterning of the chip polymer, increasing both the
interaction sites of the CTC with the antibodies as well as the throughput and speciﬁcity.[24]
The ultimate version of this isolation and sorting procedure, the CTC-iChip, uses a combi-
nation of antibody marking, hydrodynamic sorting and magnetophoretic displacement to
extract CTC from blood samples.[25] Blood is ﬁrst incubated with magnetic beads coated with
epithelial antibodies. The sample is then injected into the CTC-iChip where small blood cells
(erythrocytes and platelets) are removed by hydrodynamic separation of large cells from the
rest of the sample.[26] After hydrodynamic inertial refocusing of large cells, CTCs are separated
from white blood cells by exposition to a magnetic ﬁeld that shifts the magnetically tagged
cells towards the collection stream.
Figure 1.2: CTC-iChip. Separation and collection of CTC from whole blood sample incubated
with immunomagnetic beads. (A) Scheme of the working principles of the CTC-iChip. (B)
Picture of the actual chip. To allow multiple work modes, it is divided in two units. (C) Size
separation unit of the chip by hydrodynamic sorting. (i, ii, iii, iv) 10 μm sized green fuorescent
beadsd are separated from 2 μm sized red ﬂuorescent beads. (D) Inertial cell focusing and
magnetophoretic unit. (i) randomly mixed cells enter the focusing unit. (ii) Cells are focused by
the passage through 60 asymmetric turns. (iii) Focused cell stream is ﬂowing through a magnetic
ﬁeld that gently separates the magnetically tagged CTCs, creating two separated streams (iv).
Image from [25].
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Single-cell analyses can operate mainly on two levels: genotype and phenotype. Single-cell
genotype analyses investigate DNA, mRNA and other forms of genetic material. The main
goal is to ﬁnd aberrant mutations resulting from DNA lesions or to determine the copy number
of a particular mRNA. These analyses are often processed in three steps: ﬁrstly a lysis of the
cell, secondly an ampliﬁcation of the genetic material followed by sequencing or identiﬁcation
of the target piece of genetic material.[27] These steps are performed by the GenomePlex
Single Cell Whole Genome Ampliﬁcation commercial kit from Sigma Aldrich. Single-cells
are isolated in a small volume where cell lysis together with proteolysis are proceeded. DNA
is fragmented at random locations by enzymes to an average fragment size of 400 base pairs.
A library of primers is added to the fragmented DNA for massive ampliﬁcation, resulting in
whole genomic DNA that can be sequenced easily by classical methods. Subtle features may be
added to increase the ampliﬁcation ﬁdelity, as for example the multiple annealing and looping-
based ampliﬁcation cycles (MALBAC) method which uses a displacement polymerase[28] in
addition to randomized primers with a 27 nucleotide invariant sequence.[29] The invariant
sequence makes the second generation replicated strand loop on itself, preventing further
random ampliﬁcation. Self-looped DNA fragments are then used a template for PCR as
quasi-linear pre-ampliﬁed DNA from the chromosomes of a single-cell of origin. MALBAC
confers to the single-cell whole genomic analysis a very high sensitivity capable of detecting
single-nucleotide variations on two alleles of a cell.
On the phenotypic side of single-cell analyses, proteins are detected for the characterization of
diseases. Proteins can be probed directly, by measuring their presence, quantity or activity, as
well as in indirect manner by probing the whole cell properties in a speciﬁc way linked to the
protein of interest. In difference to genetic material, proteins cannot be ampliﬁed to increase
the quantity of material to analyse. The average total number of proteins in one single cell is
about 108, for a total mass of approximately 75 pg of protein per cell.[30] This gives, for a low
expression level protein of interest, a total copy number of approximately 104 in one single cell
available for detection.[31] Detection methods must thus be sensitive enough to capture the
information in very low concentration or rely on spatiotemporal conﬁnement of the proteins
of interest. The use of optical biosensors is among the most widely used ways for monitoring
the number and activity of molecules in cells, in particular ﬂuorescent biosensors. They may
be divided into synthetic and genetically encoded biosensors. Synthetic ﬂuorescent sensors
are typically small organic molecules that change their ﬂuorescence properties upon sensing
a biological property, such as the concentration of a soluble molecule or the pH.[32] Many
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different genetically encoded ﬂuorescent reporters have been developed. In this context, the
expression of ﬂuorescent fusion proteins has been a major breakthrough, making it possi-
ble to directly visualize the proteins of interest.[33] For example, ﬂuorescence microscopy
allows the observation of single-cell mechanics. Commonly used is the localization of ﬂu-
orescence species in a cell. Localizing molecular species gives information regarding their
role and function; for example proteins located in the nucleus are likely to be related to ge-
netic information, whereas membrane proteins are often involved in signal transduction.[34]
Changes in location of a signaling molecule can be observed upon activation of a signaling
cascade.[35, 36] Another example concerns colocalization of multiple ﬂuorescent molecules
to correlate the position and interactions of proteins inside a cell. FRET (Förster Resonance
Energy Transfer) can resolve visually spatial interactions in the nanometer range, which goes
beyond simple colocalization. This technique uses non radiative energy transfer from a ﬂuo-
rescent donor molecule to a spectrally overlapping ﬂuorescent acceptor resulting in photon
emission of the acceptor molecule upon photoexcitation of the donor. The efﬁciency of this
energy transfer relies on the spectral overlap of the two ﬂuorescent molecules, the orientation
of the respective ﬂuorophores and their distance with subnanometer precision. This method
is extensively used to monitor conformational changes of proteins, as the distances involved
are typically in the nanometer or subnanometer range.[37] In addition, genetically encoded
sensors for measuring concentration of signaling species have been developed using FRET
principles.[38, 39]
Limitations of ﬂuorescence microscopy may arise from the ﬂuorescent probe itself, in terms
of potential insufﬁcient lifetime, steric hinderance, or changing protein function. Another
limiting feature is the spatial resolution of ﬂuorescence/opticalmicroscopy, that is restricted to
approximately 200 nm the smallest distance to be distinguished. Novel developments circum-
vent this limitation of spatial resolution. Examples are PALM (Photoactivation Localization
Microscopy) [40] and STORM (Stochastic Optical Reconstruction Microscopy)[41]. They work
by stochastic activation of a small number of ﬂuorescent molecules and determining their
spatial location with nanometer precision by calculating the maximum intensity of the point
spread function of each ﬂuorescent molecule; the subset of these activated molecules is then
shut off and another subset of ﬂuorophores is subsequently activated and the location of these
ﬂuorophores is determined again. This process is repeated many times, thus determining the
position of all ﬂuorophores with nanometer precision. A superposition of all determined posi-
tions ﬁnally results in an image of ﬂuorophores with overall nanometer resolution. Another
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method of superresolution microscopy is STED (Stimulated Emission Depletion). [42] Here
the effective area of the ﬂuorescence excitation laser beam is reduced below the diffraction
limit by depleting ﬂuorophores in a ring-like shape leaving a nanometer-sized unbleached
excitation area. Only the central reduced excitation area is emitting ﬂuorescence photons,
thus increasing the localization accuracy of the ﬂuorophores down to the nanometer range.
Flow cytometry allows a rapid, yet less precise and less speciﬁc treatment of single-cells la-
beled with ﬂuorescent molecules. If localization inside the cell remains an unsolved challenge,
ﬂow cytometry is able to process thousands of cells per minute with the averaged ﬂuorescence
of the whole cell as an outcoming data. Genetic labeling of the protein of interest is commonly
used. However, due to their higher brightness, their much smaller size and the capability of
labeling other kinds of molecules than proteins, synthetic ﬂuorophores are often preferred via
post-translational labeling. Data that are not in relation with exogenous ﬂuorescence can also
be obtained, such as size, morphological characteristics or autoﬂuorescence.[43]
The major problems limiting the use of ﬂuorescence in single-cell measurements comes from
the necessity of submitting cells to a pre-treatment to introduce the ﬂuorescent molecules
inside the cell of interest, whether it is genetically encoded (transfecion) or not (permeation,
microinjection).[44, 45] An alternative method is to add the ﬂuorescent component after lysis
of the cell, which may cause dilution related loss of signal intensity.[46]
An alternative method takes advantage of the naturally ﬂuorescent amino acid tryptophan to
detect and identify proteins.[30, 47, 48] Here cells are manipulated with optical tweezers in a
PDMS microﬂuidic device to be lysed by a strong electric ﬁeld pulse. The cellular content is
then separated by electrophoresis and the proteins are detected by the intrinsic ﬂuorescence
of tryptophan residues. Finally, they are expected to be identiﬁed by their electrophoretic
displacement, although this method suffers from poor precision.
Microﬂuidic devices have been coupled to capillary electrophoresis and mass spectrometry
to perform single-cell proteomic analysis.[45] Here cells are injected in a microchip channel
to undergo detergent-free lysis mediated by a methanol-containing buffer. The cell content
then ﬂows into a channel where proteins are electrophoretically separated before analysis by
electrospray ionizationmass spectrometry. An alternative method uses MALDI-TOF, where the
proteins are immobilized on an antibody-coated surface prior mass spectrometry analysis.[49,
50]
Building up statistical relevant data sets requires the ability to analyze multiple individual
cells with sufﬁciently high throughput. Parallelization of analysis on the micrometer scale
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is one of the most common ways to achieve it. Parallelization can be realized by different
means, such as multiplication of the microﬂuidic channels[51], multiple single-cell trapping
in refractive optical tweezers[52], single-resolved cells immobilized in hydrogels[53] or cells
docked in microstructured elements[54]. An alternative is to implement an automated spatial
segregation of individual cells by the generation of immiscible microdroplets from the cell
suspension in a hydrophobic carrier ﬂuid[55], where the different liquid phases can be easily
detected and can be scaled to the sampling frequency of the detector.
The advances in single-cell measurements are on the way to revolutionize medical possibilities
towards the development of personalized treatments that are ﬁnely tuned to each individual
patient, with one’s own disease conﬁguration and own reactive pattern towards treating
agents.[56, 57, 58] Every step forwards to the achievement of quantitative single-cell analysis
is one step further towards personalized medicine.
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1.2 Optical tweezers
Among many others, light has been one of the most fascinating tools used to probe cellular
processes, using for example optical microscopy [59], spectroscopy [60, 61] or small angle
scattering [62], to mention a few. A less intuitive way of using light consists of focusing a
laser beam onto a micrometer sized object to act on it as tweezer. Optical tweezers have
been ﬁrst developed by Ashkin in 1970.[63] Thanks to multiple interactions of light with a
given small dielectric object, a laser beam with a Gaussian intensity proﬁle can trap the object
inside the beam while still pushing it forwards. It has been shown later that focusing the
laser beam with a large numerical aperture microscope objective provides the ability to trap
a particle in the focus (Figure 1.3).[64] The trapping force is generated by the deﬂection of
the electromagnetic ﬁelds as it passes the dielectric object. As the light rays change direction,
they change momentum, transferring energy to the particle. In a Gaussian laser intensity
proﬁle, the transmission process provides maximal energy in the centre of the beam because
the gradient of the electromagnetic intensity reaches its local maximum. The combination
of these two effects allows the efﬁcient trapping and manipulation of small objects in the
micrometer range in free space.[65] As these effects occur over the volume covered by the
laser beam, the forces exerted formally by individual rays have to be integrated over the entire
particle volume submitted to light. Forces delivered are in the order of pN, making optical
tweezers particularly suitable for the manipulation and investigation of biopolymers.[66, 67]
The ray-optics approximation considers that the whole laser beam is split into single individual
rays with each of them having their individual intensity, propagation direction and incident
angle on the particle.[65] Forces delivered by optical tweezers are to be decomposed in two
distinct components: a force FZ acting in the direction of light propagation, the scattering
force, and a force FY acting in the plane perpendicular to the light propagation vector, the
gradient force. These forces can be described as follows [65] :
FZ = n1P
c
{1+Rcos(2θ)− T
2[cos(2θ−2r )]+Rcos(2θ)
1+R2+2cos(2r ) } (1.1)
FY = n1P
c
{Rsin(2θ)− T
2[sin(2θ−2r )]+Rsin(2θ)
1+R2+2sin(2r ) } (1.2)
where n1Pc is the incident momentum per second of a ray of power P in a medium of refractive
index n1. R and T, respectively, are the Fresnel reﬂection and transmission coefﬁcients[68] of
the particle surface at the incident angle θ, and r is the refraction angle. The spatial integral
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covering the whole particle hit by the light beam yields the total momentum transmitted and
the force exerted to the particle by the trap.
Since optical tweezers do not require invasive interactions, it allows non-contact manipulation
of small, high refractive index objects. As the trapping force is proportional to the difference in
refractive index between the trapped object and the surrounding medium, it is easier to trap
the optically denser organelles such a nuclei or chloroplasts inside the cell than the entire cell
itself.[69, 70, 71] Further, it is easier to exert spatial control on certain cellular components
with the help of latex or polystyrene micrometer sized beads that can be used as supports or
handles for small cellular components which would be difﬁcult to trap directly. Many DNA
related optical tweezers applications have been reported using this approach.[72, 73, 74]
As the trapping laser can be directly integrated into the microscope excitation optical path, it
does not require any supplementary manipulation device. The only crucial step consists of
the correct alignment of the trapping laser to place its focus such that the movement of the
trapped object scales to the movement of the ﬁeld of view of the microscope.
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Figure 1.3: Schematic viewof a three-dimensional trapping of a spherical dielectric particle
in a focused laser beam with a Gaussian intensity proﬁle. The refraction of a typical pair of
rays a and b of a trapping laser beam exerts forces Fa and Fb whose vector sum gives a net force
F which points towards the focus of the beam f for any displacement of the sphere from the trap
focus. Thereby, the sphere is stably trapped in the trap focus. (A) Optical trapping of a spherical
object out of the laser focus in the direction of propagation of the laser beam. The instant net
force F resulting from the change in momentum of light drags the particle towards the focus.
The same physical phenomenon takes place for a particle positioned closer to the lens (B) or
aside of the focus +(C). Figure adapted from [65]
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1.3 Microﬂuidics
Miniaturization is becoming increasingly important for bioanalytical devices.[75, 76, 77]
Microﬂuidics, the miniaturization of ﬂuidic systems, offer a wide variety of platforms for
performing analysis of samples at the micrometer and (sub-)microliter scale. Fluidics reduced
down to the diameter at the micrometer scales give rise to speciﬁc properties usually not found
at macroscopic scale. For example, the dimensions of the ﬂow channels imply a very high
surface to volume ratio; in turn unspeciﬁc adsorption phenomena to channel walls become
of major importance.[78] The micrometer channel dimensions give to the ﬂow a laminar
character. Liquids ﬂowing in microsized channels are displaying a low Reynolds number
Re = ρULμ , where ρ is the ﬂuid density, U the mean ﬂuid velocity, L the characteristic length
and μ the ﬂuid viscosity.[79] As L is related to the channel’s cross-section, it is likely that at
such small scale, only laminar ﬂow is observed. In laminar ﬂows, lateral mass transfer is only
achieved by diffusion. This allows to realize separate ﬂows in one single channel, as shown in
Figure 1.4. This property is used for example in hydrodynamic focusing.[80, 81]
Microﬂuidic devices signiﬁcantly reduces the quantities of sample needed to be analyzed.
Whereas traditional macroscopic techniques require milliliters to perform a quantitative
analysis, microﬂuidics decrease sample consumption down to sub-microliters. Thanks to
the miniaturization possibilities, microﬂuidic devices allow a high degree of parallelization
of processes to greatly increase the number of simultaneous observations.[54] This saves
both consumables and time and delivers relevant statistics using a minimum ﬂow through.
Furthermore, coupling microﬂuidics to miniaturized bioanalyses created a new ﬁeld of R&D
called "lab on a chip", performing puriﬁcation, conditioning, separation and multiple analyses
of a complex sample all at once within a miniaturized device.[83, 84]
Microﬂuidic chips used in research and development phase are oftenmade of silicone polymer
PDMS (poly-dimethylsiloxane), with channels imprinted by soft lithography, glued on top
of a thin glass coverslip (Figure 2.8). PDMS is widely used for its elastic properties, its good
biocompatibility, as well as for the relative low complexity of the chip fabrication process.[85]
The elastic properties of PDMS can be tuned by varying the amount of curing agent used in
the elastomer mixture before polymerization. Tunable elasticity of the polymer is required
for multi-layer microchips if pneumatic valves are implemented.[86] PDMS has a remarkable
gas permeability, which offers the possibility to culture cells in microchips.[87, 51] Culturing
cells directly inside microchannels allows a better control of the growth conditions as well as
proper cell adherence to the bottom glass surface of the chip after adequate surface treatment.
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Figure 1.4: Illustrationof liquidﬂowing inamicroﬂuidic channel. (a) Colored liquid ﬂowing
through a microﬂuidic chip designed for establishing a gradient of three compounds. Three
liquids are injected simultaneously in a microﬂuidic channel array. After mixing in regulated
proportions in a mixing area, the resulting eight streams are merged into a single channel where
they ﬂow in parallel with very little diffusion only across the interfacial areas of streams. (b)
Scheme of the microﬂuidic chip. Image adapted from [82].
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1.4 Cancer
Cancer has become one of the biggest challenges worldwide.[88, 89] Cancer is the second
cause of death in the United States[90] and the fourth cause in the world.[91] Changes in
lifestyle, especially of dietary habits, prolonged duration of life, exposition to cancerogenic
compounds, environmental factors are a few of themany causes of cancer. Since it has become
a major life threatening shadow in the developed countries, it has also drawn the attention of
pharmaceutical research, for the potential colossal incomes that can be generated by cancer
related drugs, as well as medical related research.
Cancer results from mutations on genomic DNA that control central cellular processes related
to cell division, intra- and inter-cellular communication and cell death.[4] Genetic mutations
naturally occur with a very low probability.[92, 93] This low rate guarantees a slow process of
evolution while maintaining a genetic stability on the time scale of several generations. A gene
which has the potential to cause cancer is called "oncogene". A single oncogene mutation is
not sufﬁcient to trigger the formation of cancerous lesions, but might accelerate the rate of
DNA mutation and produce a long cascade of cellular malfunctions leading ultimately to cell
death.[94] In rare occasions, when the mutations are affecting a combination of oncogenes or
tumor suppressor genes, cells may develop a cancerous behaviour.[95, 96]
Six main cellular functions are commonly described to play an important role in cancer
development.[4] (1) Resistance to cell death implies that the cell becomes insensitive to
apoptosis.[97] (2) Resistance to senescence allowing the cell the capability of performing
endless replication.[98, 99] (3) Resistance to external growth suppressing signals making the
proliferation of cells independent to external mechanisms for holding the unhealthy cells to
a normal division rate.[100] (4) In order to proliferate, cancer cells provide growth signal to
the cell machinery.[101, 102] (5) To provide the nutrients necessary to growth of cancer cells,
angiogenesis is promoted through expression of vascular growth factors.[103, 104] (6) The
ability of invading other tissues.[105, 106, 107] p53 is one of the central proteins in relation
with cell proliferation and protection of a controlled cell division, as well as with programmed
cell death.[108, 109, 5] A mutation on the gene of p53 disrupts its activity in the majority of
malignant tumors.[110]
Early detection of cancerous lesions is crucial for patient survival; mortality increases rapidly
with malignancy progress, as do healthcare costs.[111, 112] Early cancer diagnosis relies on
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Figure 1.5: Progression from healthy tissue to cancer. One of the various possible paths of
evolution from a healthy tissue to a malignant cancer. A succession of mutations is necessary to
break safety barriers to turn a normal cell into an immortal uncontrolled proliferating cancer
cell with uncontrolled DNA mutation rate and invasive behaviour. Image from the American
National Cancer Institute.
the detection of biomarkers found in body ﬂuids or in sick tissues.[113, 114, 115] If tumors are
treated before reaching a high level ofmalignancy, they do not spread and remain at a relatively
low level of genetic diversity, which makes them easier to erase. Although radiotherapy is
widely used for treating a variety of cancers[116], it is limited to the treatment of tumors
restrained to small volumes and local areas. Broad spectrum anticancer drugs used for
radiation resistant or spread cancers are most often of a high systemic toxicity, especially
for kidneys, stem cell-rich tissues and fast replicating cells, making their usage difﬁcult to
stand for patients.[117, 118, 119, 120, 121] As such, a complement for making the remission
of patients easier is the administration of drugs targeting speciﬁcally cancerous cells with as
little damages to healthy tissues as possible. The concept of "magic bullet" has been a long
time aim of the pharmaceutical industry.[122, 123] A magic bullet is a drug that targets cells
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suffering from a speciﬁc ailment causing minimum harm to healthy cells. Magic bullets rely
on the use of recognitions elements (antibodies, ligands) that have a designed interaction site
with biomarkers of cancer cells. It increases the efﬁciency of the administrated dose while at
the same time decreases side effects on fragile organs. Prerequisites to design such a drug is to
have reliable methods to detect the molecules indicating a favourable phenotype for the use
of a speciﬁc drug as well as a good knowledge of a way to deliver efﬁciently the drug to the
targeted cells.
Since one of the features of cancer is phenotypic heterogeneity, it appears necessary to apply
detection means on a single-cell basis.[124] It is indeed very common to ﬁnd multiple popula-
tions of cells with various characteristics, each of them having undergone a genetic separation
during the evolution process of the genomically instable tumor.[125, 126, 127] New popu-
lations have different behaviours in terms of invasiveness, stiffness or drug resistance.[128,
129, 130] The later point renders crucial the deciphering of the tumoral phenotype complex
partition in order to eradicate all malignant cells in one single drug treatment, in particular in
case of a spread cancer.[131, 132, 133]
Alternative curing strategies are being investigated to greatly decrease the toxicity of treat-
ment agents used in cancer therapy.[134, 135, 136, 137] The choice of one or another depends
strongly of the response to the treatment of the cancer itself as well as the response of the pa-
tient. Gene therapy is one of those; it relies on the introduction of exogenous genetic material
or the silencing of overexpressed proteins in cells of patients.[138, 139] The focus of this tech-
nique is on the means for delivering genes to the desired body area. Cargos made of artiﬁcial
lipid vesicles have already been investigated in that direction, although with limited success
so far.[140, 141, 142] Artiﬁcial vesicles have to be extensively modiﬁed to acquire fusogenic
properties as well as prolonged life-time for an acceptable potential efﬁciency. Adenoviruses
have provided promising yields as DNA cargos.[143] Recent observations have underlined the
role of extracellular vesicles (EVs) naturally produced by cells with remarkable properties for
cellular intercommunication.[144] EVs derived from cancer cells transfer tumor speciﬁc pro-
teins and genetic material to the whole body of patients via circulatory systems.[145, 146, 147]
There is hope that EVs in body ﬂuids can be used as biomarkers for early detection of diseases
such as cancer.[148] Taking advantage from their high performance in modifying behaviour
of other cells, the use of EVs as carrier of chemicals of genetic material for gene therapy is a
present focus of research groups on the edge of cancer therapy.[149]
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2 Probing plasma membranes with
optical tweezers
2.1 Introduction
The properties of the plasma membrane are tightly related to the type of cell and to its
physiological condition.[150, 151, 152, 153] This implies that not only a cell and its plasma
membrane of a given tissue will be different from a cell of another tissue, but also that two
cells of apparent identical origin could exhibit different properties according to differences
in age and environmental inﬂuences like local stress, action of pathogens or epigenetics to
mention a few.[154] This chapter concerns the viscoelastic properties of living cells probed
by optical tweezers. Recent reports indicate that biological cells can be distinguished by
their mechanical properties.[155, 156, 157, 158] Here the invasiveness of cell is compared
to their stiffness. The stiffness is measured using stretching lasers [155], magnetic tweezers
[156] or atomic force microscopy [157, 158], with the converging observation that the stiffer a
cell is, the most invasively it behaves, hence providing a potential mechanical biomarker for
cancer evolution. Here we investigate whether it is possible, with the help of optical tweezer
technology, to investigate cancer cells from tumors through the viscoelastic properties of their
plasma membrane and thereby follow the process of the tumor development. The focus of
this study is put on human skin melanoma, a malignant tumor of the skin melanocyte.[159]
2.1.1 The cell membrane
The plasma membrane of a mammalian cell is composed of thousands of different lipids and
a plethora of transmembrane proteins.[160, 161, 162, 163] It deﬁnes the border of a biologi-
cal cell and mediates actively the communication between the inside and outside of a cell,
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Figure 2.1: The three main lipids constituting the cellular plasma membrane. (a) Phos-
pholipids (or phosphoglycerides) are made out of two hydrophobic fatty acid chains (black)
connected to the polar phosphate head group by a glycerol moiety (magenta). On the blue
frame are given a few examples of the many possible moieties found on the phosphate group,
here ethanolamine, choline, serine and inositol. (b) Cholesterol is constituted by a four-ring
rigid sterol moiety to which are attached a hydrophobic tail and a polar hydroxyl group. (c)
Sphingolipids are built from the sphingosine moiety (magenta) to which is attached a fatty acid
chain (black) and a polar head group; here are shown sphingomyelin and glycosylcerebroside
on the green frame. Image adapted from [1]
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harboring the central cellular signal transduction machineries. Plasma membranes show a
very heterogenous composition which varies drastically between different cell types, but are
changing very dynamically over time and space even within one single cell.[160, 161, 162] The
membrane lipids are organized in form of an asymmetric ﬂuid bilayer, allowing the insertion of
transmembrane proteins or the attachment of particular proteins at membrane surface via po-
lar lipid headgroups.[164, 165, 166] The three principal classes of plasma membrane lipids are:
Phospholipids (Figure 2.1.a) are constituted of two acyl chains anchored to a glycerol group
that connects them to a phosphate group; the phosphate group can be functionalized with
various polar components, such as choline, ethanolamine or sugar molecules. Sphingolipids
(Figure 2.1.c) are made of an acyl chain attached to a sphingosine moiety; the polar head can
also have various functional groups attached, such as phosphatidylcholine or sugar molecules.
Cholesterol (Figure 2.1.b) is a sterol that plays a role in the spatial organization of the mem-
brane components.[167, 168, 169] The lipid bilayer functions as a two-dimensional liquid. Its
dynamics depend on the temperature, the lipid composition, the presence of cholesterol and
other membrane components such as proteins.[170, 171, 172, 173, 162]
Transmembrane proteins mediate communication across the cell membrane to regulate
many functions of the cell. Transmembrane proteins contain in their primary structure
one or several sequences of hydrophobic amino acids allowing stable incorporation into
the lipid bilayer. Transmembrane proteins are integral parts of the plasma membrane and,
together with membrane lipids, can form transient microdomains that are important for
the organization of the membrane and for activation of biological processes.[171, 162] Since
the plasma membrane is highly elastic, it can adopt various shapes that are modulated by a
dense network of structural proteins of the cell’s cytoskeleton such as microtubules or actin
ﬁlaments.[174] Cells adopt tissue-speciﬁc shapes[175] which, for example during evolution of
cancer, are substantially modiﬁed.[176]
2.1.2 Probing viscoelastic characteristics of cell membranes
Mammalian cells are continuously changing their shape as they are (i) moving (motility), (ii)
probing their environment or contacting neighboring cells via ﬁlopodia or membrane nan-
otubes for exchanging physical and chemical signals, or (iii) undergoing external mechanical
stress.[177, 178, 179, 180, 181, 182, 183] Figure 2.2 shows typical examples of cultured cancer
cells which continuously are sending out ﬁlopodia-like nanotubes to ﬁnally establish con-
tact with neighboring cells for intercellular exchange of cellular components and molecules.
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Figure 2.2: Scanning electron micrographs of cultured cancer cells sending out ﬁlopodia-
like nanotubes. Some nanotubes make direct contact with a neighboring cell for intercellular
exchange of compounds. Image from [179]
In consequence, cellular membranes, primarily the plasma membranes, are permanently
changing their shape. In order to describe these membrane shape changes in physical terms
and to assign energies to the different membrane conﬁgurations, it is useful to distinguish
the different membrane deformations in the framework of continuum elasticity theories (see
chapter 11 in [184]). As shown in Figure 2.3, the principal deformations of a cell membrane
can be described as stretching of a membrane, bending of a membrane, thickness defor-
mation of a membrane, and shearing of a membrane. In cells, the deformations of plasma
membranes are linked to complex processes between membrane proteins, cytoskeleton and
motor proteins.[185] It is therefore not surprising that the ﬁrst experimental approaches to
understand the mechanical and viscoelastic properties of membranes are undertaken using
model membranes in form of giant unilamellar lipid vesicles (GUVs).[186, 187, 184, 188]
Elastic properties of pure lipid bilayers measured by stretching vesicles
The classical approach introduced by Evans and Needham is based on a micropipette aspira-
tion technique, schematically outlined in Figure 2.4. A glass micropipette is brought in contact
with a spherical GUV. The vesicle is then partly sucked into the pipette under controlled pres-
sure, which results in a deformation of the vesicle. On the basis of the measured geometrical
parameters using video microscopy and the known pressure difference between the inside
of the vesicle and the inside of the pipette, it is possible to determine the membrane tension
and the membrane’s material properties such as the bending modulus Kb and the area stretch
modulus Ka . On the basis of measured geometrical parameters of pipette aspirated vesicles
(Figure 2.4) an expression of membrane tension γ and area stretch modulus Ka was derived as
[186]:
γ= Δp
2
· Rl
1− RlRv
(2.1)
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Figure 2.3: Schematic depiction of the principal deformations of a cell membrane. Cell
membranes can be subjected to stretching, bending, thickness changes or shear. Shear deforma-
tion is characterized by an angle θ describing the deviation from the undeformed membrane.
Image modiﬁed from [184]
Figure 2.4: Pulling of a membrane tube from an lipid vesicle. The suction of a micropipette
is used to pull a tube out of the membrane of a lipid vesicle. Left: the bigger the aspiration force
is, the longer the tube is elongated. Right: the physical parameters used in equations 2.1 and 2.2
for the calculation of the membrane tension γ and stretch modulus. Image adapted from [184]
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where Δp = pin −pout is the pressure difference between the inside of the micropipette and
the medium surrounding the vesicle;
and
γ=KaΔa
a0
=Ka ·R2l ·
1+ l ·Rl
2 ·R2v
(2.2)
where Δa is the membrane area change during vesicle aspiration and a0 is the area of the
vesicle at the resting state.
In the vesicle aspiration experiments, the size and shape of the aspirated membrane tube is
constrained by the geometry of the micropipette. However, membrane tubules formed by
cells are quite different extending as long, cylindrical structures from the plasma membrane
reservoir. Considering a lipid vesicle as the most simpliﬁed model of a cell membrane again,
the question arises, whether a pulling force applied at a deﬁned point at the vesicle surface will
ﬁnally produce an extruded membrane tether of micrometer or nanometer diameter. This was
realized experimentally by applying a point force on the vesicle surface via a locally attached
microbead, which was pulled at a deﬁned force by either an optical or a magnetic tweezer, or
by reconstituting molecular motors at the vesicle surface as depicted in Figure 2.5. From these
pulling experiments both the bending modulus Kb and the tension γ of the membrane can
be determined according to the relation of these properties to the tether diameter r and the
pulling force f (see Figure 2.5):
r =
√
Kb
2 ·γ (2.3)
f = 2 ·π ·√2 ·Kb ·γ (2.4)
The seminal micropipette aspiration and optical tweezer pulling experiments on lipid vesicles
revealed for the ﬁrst time the viscoelastic properties of pure lipid bilayers and opened the
door for subsequent experiments on plasma membranes of living cells. In the context of
the present thesis chapter, the following ﬁndings are of importance. The measured forces
required for drawing a membrane tether from a lipid vesicle or from the plasma membrane
of a mammalian cell are in the order of 10 pN (Figure 2.5-E). Rewriting equation 2.4 yields
γ= f 2/(4 ·π2 ·2 ·Kb). Typical values for the bending modulus are in the order of Kb ∼ 50 ·kb ·T
(kb ·T = 4 pNnm ) deduced from Ka values[189] according to Kb = 112 ·Ka ·d2 where d is the lipid
bilayer thickness (this holds for the case of a lipid bilayer with coupled monolayers and
uniform stress modulation).[187] Using these data we obtain γ= 0.01 pNnm (or mNm ) as a typical
order of magnitude for the tension of a lipid bilayer and in turn from equation 2.3 r ∼ 50 -
100 nm as the diameter of the pulled membrane nanotube which nicely ﬁts to the dimensions
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Figure 2.5: Extrusion of tubes by the application of a point force at the membrane of lipid
vesicles. (A) Schematic elongation of membrane tube from a lipid vesicle with the help of
molecular motors attached to the membrane and guided by microtubules. (B) Elongation of
membrane tubes over a mesh of microtubules. (C) In 11 s, the molecular motors drive the
elongating membrane tether along several tracks of microtubule over 10 μm. (D) Elongation of
a vesicle membrane nanotube using an optically trapped bead attached to the membrane. (E)
Time vs force recording of an experiment such as in (D). The force needed to extract a tether is
in the order of 10 pN. Once extracted, the elongation of the tube requires no higher force. (F)
Schematic model of a tether elongated by application of a point force on the membrane of a
vesicle. Image adapted from [184]
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of plasma membrane nanotubes for cells reported elsewhere.[179, 190]
A nanotube pulled by a point force from an optical or magnetic tweezer can be retracted
by switching off the point force. The back-relaxation typically follows single exponential
kinetics (see equation 2.6) from which viscoelastic properties of the membrane system can be
determined using the following equation:
τ≈ ηm +ηL0
μ
(2.5)
Here τ is the relaxation time for elongation length L0, ηm the membrane viscosity, η the
viscosity of the surrounding aqueous medium and μ the membrane shear modulus. This
kinetic description has been used to evaluate viscoelastic properties of the plasma membrane
nanotubes of (i) HEK cells drawn with optical tweezers[191] and (ii) RB cancer cells drawn with
magnetic tweezers.[190] As underlined by several studies, addition of chemicals impairing
the cell’s cytoskeleton diminishes the force needed to pull membrane tethers and increases
nanotube relaxation time.[192, 193, 191]
2.1.3 Optical tweezers/microﬂuidic microscope
The optical tweezers microscope used in this thesis was designed by Michael Werner.[53] It
consists of a commercial wide ﬁeld inverted microscope (Axiovert 200M, Zeiss) equipped with
different objectives. A couple of lasers for ﬂuorescence excitation at different wavelengths are
available. A selected laser is fed into the objective (Plan-Apochromat 100x/1.45 Oil, Zeiss) for a
wide ﬁeld illumination. A 100x objective is particularly suited for the observation of micron-
sized objects (membrane nanotubes, beads of chapter 3). The large numerical aperture of
this objective ensures a high trapping efﬁciency of the optical tweezer, as the trapping force
depends on it. Typically used lasers have wavelengths at 488 nm (500 mW max output, JDS
Uniphase, for excitation of eGFP in chapter 3) and 543.5 nm (5 mW max output, Melles Griot,
for excitation of Texas Red in chapter 3). For optical trapping, we used an Ytterbium near
infrared laser at 1064 nm TEM00 mode (YLD-10-1064-LP, IPG Photonics) with a maximal
output power of 10 W. This infrared laser is ideally suited to work on biological samples
because of its high penetrative power and low absorption in tissues. Hence, only little energy
is dissipated in the living tissues, reducing the risks of photodamaging the plasma membrane.
A large portion of the infrared laser power is lost passing the optics, the immersion oil and the
glass coverslip; the ﬁnal output power at the sample is reduced to 2.6% of the output power at
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the optical ﬁber (measured with a power meter model 2930C and a photodiode sensor 818
SL, Newport). Hence, the surface power of the optical trap ranges from 0.24 to 25·106 Wcm2 on
the 1 μm2 surface of the optical trap focus. All images, videos and real-time monitoring, in
transmission and in ﬂuorescence, are recorded with a CCD camera (Pixelﬂy, PCO).
Microﬂuidic components are coupled to the optical tweezer microscope. Two 100 μl glass
syringes (Hamilton) are installed on two separate two-syringe pumps (SP 210 IWZ, WPI) to
create the main ﬂows of the system. The pumps are controlled by a home made Labview
interface (National Instruments). PTFE tubes (FEP Fluoropolymer Tubing, DuPont) connect
the syringes to directional valves. Three-path valves are connected to the syringes on the
pumps and to a large-reservoir syringe to ﬁll up the pump syringes which are connected
to the microchip. The chip is placed on the sample stage of the microscope to allow direct
observation of processes inside the channel such as manipulations performed by the optical
tweezer. An output PTFE tube connects the chip to a waste collector.
Figure 2.6: Scheme of the optical tweezer, ﬂuorescencemicroscope setup. Laser 1 is the 1064
nm TEM00 near infrared laser used for optical trapping. Laser 2 and Laser 3 are ﬂuorescence
excitation lasers, emitting light at 488 and 543.5 nm, respectively. L1 is the ﬁrst lens to focus the
trapping laser. L1 together with lens L2 serve as a telescope in order to adapt the diameter of the
laser beam such that it slightly overﬁlls the objective’s back aperture. L3 and L4 are controlling
the diameters of the beams of Laser 2 and Laser 3. LS is the shutter to control ﬂuorescence
excitation. DM1 and DM2 are dichroic mirrors allowing the superposition of the three lasers
into the same optical path of the microscope objective and to isolate the output ﬂuorescence
signal of the sample. MO is the microscope objective focussing axcitation and trapping beams
and collecting ﬂuorescence. FF are the ﬁlters to isolate the ﬂuorescence signal. CCD is the CCD
camera to record images of the sample. Figure modiﬁed from [194].
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Figure 2.7: Photo of the optical tweezer setupwith integratedmicroﬂuidic components used
in this work. The upper stage is dedicated to the ﬂuorescence excitation lasers, which join the
optical path of the trapping laser on the lower stage before entering in the back side of the
microscope. Valves, tubing and syringes are part of the microﬂuidic components.
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2.2 Experimental
2.2.1 Requirements for optical trapping
As the laser based optical trap generates heat, the medium surrounding the sample is exposed
to a temperature gradient that creates a convective ﬂux in the surrounding bulk liquid. Cell
culture tends to generate a large amount of micro-debris of organic materials ﬂoating all
around the cells under consideration. Focusing a laser in a large aqueous medium hence give
rise to unwanted liquid displacement which is not only disturbing by itself, but also contin-
uously feeding the laser focal spot with undesired organic material that tends to fuse with
soft trapped elements such as cell membranes. To prevent this to occur, all the experiments
described in this chapter have been performed in microchannels. The limited size of the
volume of the "sample compartment" exposed to the laser insures a locally homogeneous
distribution of heat, suppressing any unwanted convective ﬂux and thus preventing cell debris
to get transferred towards the optical trap. Hence we performed our analyses in microﬂuidic
channels with the lowest height possible, which turned out to be 50 μm.
All liquids used for the microﬂuidic experiments have been carefully ﬁltered to prevent large
particles clogging the microchannels, especially when using chips with micrometer-sized
cross-sections. Liquids also have been carefully degassed in order to avoid the formation of
air bubbles in the microﬂuidic channels. Air bubbles can either clog the channels or destroy
the glass bottom of the microchip by extremely fast dilatation when passing in the focus of the
laser tweezers.
2.2.2 Cell culture
After taken from the patient’s tumor, the primary melanoma tumor cells were cultured in
plastic culture ﬂasks (Tissue culture ﬂask, TPP) in Tu 2% medium composed of 79% MCDB
153 medium (Sigma) supplemented with sodium bicarbonate (Sigma), 19% L-15 medium
(Sigma), 2% NBCS (Sigma) and 0.5% bovine insulin (from bovine pancreas, Sigma), with the
addition 100 μgml of a preparation of penicillin and streptomycin (AppliChem) in a 34 °C sterile
cell culture incubator.
HEK cells were cultured in cell culture medium (DMEM/F-12 GlutaMAX™ Supplement, Life
Technologies) supplemented with 10% NBCS, penicillin and streptomycin.
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2.2.3 Microchip fabrication
Fabrication of microchips follows the method described by McDonald et al..[195] It starts
with the design of the geometry of the channel paths using the software QCad (RibbonSoft)
to elaborate the desired microﬂuidics features. The design is transferred to the software
AutoCAD (Autodesk) to be exported as a correct ﬁle type (.dwg) that was sent to the Stanford
Microﬂuidic Foundry (Stanford University) for the creation of a negative silica mould which
was used for serial chip fabrication. A mixture of PDMS elastomer and curing agent (Sylgard
184 silicone elastomer kit, Dow Corning) is poured on top of the mould to reach a ﬁnal layer
thickness of approximately 5 mm. Bubbles are removed under vacuum for 2 hrs and the
liquid is placed overnight in a 80°C oven for curing. Cured chips are cut from the mould,
inlet holes are punched with a custom sharp edge steel tube 1.2 mm diameter. Chips are
cleaned by sonication 15 min in ethanol, 15 min in water, 15 min in ethanol and dried under
nitrogen stream. Rectangular 24 mm x 50 mm glass coverslips (Menzel-Gläser) are cleaned by
sonication three times 15 min in alkaline detergent (Hellmanex II, Hellma Analytics), three
times 15 min in Milli-Qwater, once 15 min in methanol and stored in ethanol. Coverslips
are dried under nitrogen stream and put together with dried chips in a plasma cleaner (Harrick
Plasma) for ﬁnal cleaning and surface activation for 1 min. PDMS chips are laid on top of
coverslips and pressed to remove air bubbles. Full chips are exposed over 1 hr to UV light for
completing PDMS to glass bonding.
Figure 2.8: Examples of two microﬂuidic chips, both depicted with empty channels and
channels ﬁlled with colored liquid. Left: The chip has a channel height of 50 μm and has been
used for the experiments described in chapters 2 and 3. Right: The chip has a channel height of
20 μm and has been designed to make successive dilutions by a factor of two over three orders of
magnitude of one component as the other remains at a constant concentration.
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2.2.4 Attaching cells inside microﬂuidic chip
Microﬂuidic channels are incubated 1 hr with a poly-L-Lysine solution to promote cell adher-
ence to the glass surface. Cells from a conﬂuent 25 cm2 culture ﬂask are detached with a 5
mM EDTA solution, centrifuged at 290×g and resuspended in EDTA-free cell culture medium
(DMEM, Life Technologies). Cell suspension is injected very slowly with a syringe into the
Poly-L-lysine treated microchip with multiple pauses in the injection process for allowing the
cells to sediment and adhere to the surface. The syringe is removed and the chip is put in a
37°C cell incubator during several hours for allowing the cells to recover and grow.
2.2.5 Membrane relaxation experiments
The focus of the laser of the optical tweezers is placed on the very edge of the plasma mem-
brane of a cell in a microﬂuidic channel, slightly above the glass surface of the chip, and the
power of the laser is increased until it traps the cell membrane. The plasma membrane is
pulled out of the cell. At the maximum elongation distance, the laser tweezer is switched off
and the back-relaxation sequence of the plasma membrane is recorded. Data are analyzed
with the software ImageJ (Wayne Rasband, National Insitutes of Health). Experiments are
done in PBS (Dulbecco’s modiﬁed phosphate buffered saline, Sigma).
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Figure 2.9: Panel of the abnormal behaviour of human skin melanocytes, from the inoffen-
sive naevus to the lethal metastatic melanoma. Referring to our tumor cell samples, SBCl2 cells
are in the radial growth phase, WM115 cells in the vertical growth phase and WM239A cells are
lymphatic node metastases. Image from [159]
2.3 Results and discussions
2.3.1 Melanoma tumor cells
Three different kinds of human skin melanoma cell strains were kindly provided by Dr. Agnese
Mariotti (CHUV, Lausanne, Switzerland) and were used to investigate the viscoelastic proper-
ties of their plasma membranes. The three different samples of cancer cells have been taken
from tumors at different stages of the evolution of a skin melanoma. SBCl2 [196] are primary
tumor cells in the radial growth phase. They are typically growing on a local base, sticking
to the epidermis, and do not invade neighbouring tissues.[197] WM115 [198] are primary
tumor cells in the invasive vertical growth phase. At this growth phase, the tumor cells start to
expand through the adjacent layers of skin and become invasive towards neighbouring tissues.
WM239A [198] are tumor cells form lymph-node metastases. At this growth phase, malignant
cells spread over the patient’s body via the circulatory blood and lymphatic systems.[199]
When they ﬁnally get ﬁxed at a suitable place in a different organ, a secondary, metastatic
tumor starts growing.[200]. Both WM115 and MW239A were taken from the same patient.
Figure 2.9 shows the evolution of the different phases from a clinically not relevant nevus to a
metastatic malignant melanoma. As three samples of tumor cells exhibit substantially differ-
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Figure 2.10: Morphological comparison of the three melanoma cells with HEK cells. The
plasma membranes of SBCl2 cells are less optically contrasted than those of the other cells.
WM115 cells organize themselves in form of an irregular network.
ent morphologies, we expected to detect differences in their viscoelastic properties. Figure
2.10 shows the morphological differences of our three different cell types visible in the optical
transmission microscopy images; the spatial organization of the cells in different stages of
tumor evolution differs substantially. We observed that the WM115 cells never reached 100%
surface conﬂuence while cultured, but rather adopted a mesh-like two-dimensional pattern.
2.3.2 Pulling membranes with no handles
The aim of the project was to investigate the capability of discriminating three different cellular
states of human skin melanoma cells by observing the relaxation of membrane nanotubes
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pulled out from the cellular body by optical tweezers. For this, we used the method developed
by Pascoal et al.[191] to pull a membrane tube without any external object that could act as a
physical handle. The ﬁrst trials were done by focusing the laser tweezer on bare cells in a large
depth culture dish. As explained in section 2.2.1, under these conditions the trapping laser
beam generated a convective stream in the surrounding liquid inducing aggregation of cellular
micro-debris in the focus of the trapping laser. The decision to perform the experiment in an
microﬂuidic environment allowed to suppress totally the laser-induced convective stream
and to prevent accumulation of cellular debris in the trapping laser focus. A slight increase of
the temperature in the immediate surrounding of the trapping focus was a minor concern, as
the measurements were performed at room temperature and locally produced heat efﬁciently
dissipated to the bulk liquid, glass and PDMS.
Figure 2.11: Microﬂuidic chip in which the membrane pulling and back-relaxation experi-
ments were performed. The two auxiliary side channels were blocked (yellow elements) to leave
only one main functional channel in which cells were grown and probed.
Cells cultured in a microchip as described in section 2.2.4 adhered strongly to the polylysine-
treated glass surface. Hence the cell membrane could be manipulated properly under a very
gentle liquid ﬂux. To pull a nanotube out of a cell, the trapping laser was directed to the edge
of the cell. When switching on the laser, the membrane is attracted to the trap. The focal point
of the laser is then moved away over distances ranging from 5 to 45 μm (example of the pulling
and relaxation of one nanotube in ﬁgure 2.13 (A) and (B)). Up to three different nanotube
pulling experiments could be achieved on a single cell without observing cellular damage.
Successful experiments pulling plasma membrane nanotubes were much more frequent and
required a lower laser power for WM239A cells than for SBCl2 cells. This is due to a bigger
difference in refractive index between the buffer and the metastatic cells than for the cells in
radial growth phase (See Figure 2.10). Laser output power of 5 W (approximately 130 mW at
the cell) was sufﬁcient to pull rather successfully nanotubes from WM239A cells or WM115,
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whereas at least 8 W (approximately 210 mW at the cell) was needed to do so for SBCl2.
When pulling nanotubes from the plasma membrane of cells, they can rupture off after a
certain distance resulting in the formation of a spherical vesicle of a size of 1 to 1.5 μm. These
cell-derived vesicles comprise part of the cellular membrane and cytoplasm and can be used
as closed cargoes for analysis of transmembrane signaling processes.[201] Alternatively to
using laser tweezers, native vesicles can be extracted from living cells by exposing the cells to
cytochalasin B, which is known to disrupt the interaction of the cell’s plasma membrane to
the cytoskeleton.[202]
Figure 2.12: Vesicle extraction from aWM239A cell. If the nanotube is pulled beyond a thresh-
old length, it ruptures off from the cell and reorganizes as a spherical vesicle. Scale bar = 10
μm.
2.3.3 Back-relaxation of pulled nanotubes
After a membrane nanotube has been pulled out from the surface of a cell and the optical
laser trap is switched off, the membrane nanotube retracts (Figure 2.13). The membrane and
cellular structural proteins undergo a rearrangement process to recover from the deformation.
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This causes the nanotube to quickly retract from its tensed elongated state and shrink back as
close as possible to the original resting state of the plasma membrane on the surface of the
cell. The time-dependence of the relaxation process follows a monoexponential decay:
L(t )= L0 exp( t − t0
τ
)+L∞ (2.6)
L(t) is the length of the nanotube at time t, L0 the elongation length of the nanotube a time t0
at which the laser is switched off, τ the characteristic relaxation time for a speciﬁc elongation
length (see eq. 2.5), and L∞ the residual length of the nanotube at inﬁnite time. The residual
length appears to be related to the large deformation of the membrane and the photodamage
occurring sometimes at high laser power. Nanotube relaxation is a process not fully understood
yet, but it is highly probable that the tubes contains cytoskeletal elements taking part to the
membrane rearrangement.
Relaxation process during retraction of the nanotubes has been measured by monitoring
the length of the nanotube as a function of time after switching off the trapping laser. The
recordings were processed at 10 frames per second to reach an optimal compromise between
visibility of the nanotube extremity and the sampling frequency. The length is measured in
pixels with the software ImageJ and converted into micrometers. The three melanoma cell
lines, SBCl2, WM115 and WM239A, exhibited a relaxation time linearly correlated with the
nanotube elongation length (Figure 2.14). The analysis of variance (ANOVA) [203] shows a
signiﬁcant effect of the elongation length on the nanotube relaxation time (p-value= 2.3·10−6).
Moreover the analysis shows a statistical relevant distinction between the cancer cell types (p-
value = 2.49·10−8). A deeper analysis performed by Tukey’s honest signiﬁcant difference (HSD)
test [204] reveals a statistical signiﬁcant distinction between WM115 and SBCl2 (p-values =
1.8 ·10−5) and between WM115 and WM239A (p-values = 7.9 ·10−5). In contrary, there is no
statistical signiﬁcant difference between SBCl2 and WM239A (p = 0.70).
The plasma membrane of WM115 cells shows a proﬁle denoting a higher deformability and
a longer time to get back to its membrane resting state, whereas the membranes of SBCl2
and WM239A cells are stiffer and relax back faster to the initial position. The viscoelastic
parameters calculated from the measured relaxation times using equation 2.5 are depicted
in table 2.1. While the membrane viscosities determined here for the melanoma cells are
similar as those found for other cells investigating membrane tubes (with the exception of RB
cells which show an order of magnitude higher values), the shear moduli of the melanoma
cells are considerably lower than those reported for all other cells (Table 2.1). The variation of
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Figure 2.13: Three steps of the pulling and relaxing experiment. (A) The laser is positioned at
the membrane edge and switched on. The optical tweezers become effective and trap the plasma
membrane. (B) The membrane nanotube is pulled over a few tens of micrometers. (C) The laser
is switched off; the trap is no more effective and the nanotube rapidly relaxes back to its original
position at the cell surface. Sometimes, after the relaxation process, a small deformation L∞
remains at the plasma membrane of the cell surface. Scale bar = 10 μm.
shear moduli of the different cancer cell types determined by our optical method showed a
qualitatively similar trend as the Young’s moduli reported by Weder et al. [205] on the same
cancer cells, but investigated with a different method, (table 2.1). For their experiments, 5 μm
glass spheres were glued to the tip of an AFM cantilever and the tip was moved up and down
with an amplitude of 500-1000 nm on top of the cell up to a maximal force of 500 pN. Young’s
moduli were calculated via Hertzian ﬁt of the force-distance curves. This model approximates
the entire cell as an isotropic and linear solid. This model is widely used to characterize
the elasticity of whole cells although the cell is known to be a highly heterogeneous and
anisotropic assembly of biopolymers.[206] In order to compare the the values of the Young’s
moduli in table 2.1 [205] with the shear moduli of the melanoma cells in table 2.1, we attribute
the Young’s modulus of a cell exclusively to its two-dimensional plasma membrane. In this
approximation we can calculate from Young’s modulus Y the membrane shear modulus μ:
μ= Y ·d
3
(2.7)
where d = 6 nm is the thickness of the cell’s plasma membrane [207](Chapter 11, p. 339). The
corresponding values are depicted in table 2.1. The thus derived values for the shear moduli
are about 30-50 times higher than those determined by the membrane nanotube method,
indicating that the Young’s moduli determined by the AFM method reﬂects a composition
of the cell membrane and all the underlying cellular components as a whole, whereas the
nanotube method characterizes primarily the viscoelastic properties of the cellular plasma
membrane and the parts of the cytoskeleton directly attached to this membrane. The relative
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Figure 2.14: Relaxation time vs nanotube elongation length. The following viscoelastic prop-
erties are deduced from this graph:
SBCl2: ηm = 1.5±0.4·10−5 mN·s/m, μ = 1.8±0.4·10−5 mN/m
WM115: ηm = 1.1±0.1·10−5 mN·s/m, μ = 9.2±1.0·10−6 mN/m
WM239: ηm = 1.0±0.2·10−5 mN·s/m, μ = 1.8±0.4·10−5 mN/m.
For comparison, data measured on HEK cells in another study using the same method [191]:
HEK: ηm = 1.5·10−5 mN·s/m, μ = 8.3·10−5 mN/m.
ηm is the membrane viscosity and μ the membrane shear modulus.
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Cell/vesicle type Treatment Membrane viscosity ηm mN·s/m Shear modulus μmN/m Reference
GUVs SM/Chol 1:1 7.1·10−5 [208]
GUVs SOPC 9·10−6 [208]
GUVs SOPC/Chol 1:1 1.2·10−5 [209]
RBC none 6-8·10−4 6·10−3 [210]
RBC none 5-7·10−3 [211]
RBC none 2.5·10−3 [212]
RBC none 8.8·10−4 6.1·10−3 [213]
HEK none 1.5·10−5 8.3·10−5 [191]
HEK Cytochalasin B 3.5·10−6 4.9·10−5 [191]
HB none 1.6 (AFM) or 1.2 (MT) ·10−5 4.5·10−5 [190]
HB Latrunculin 0.8 (AFM) or 1.1 (MT) ·10−5 8.4·10−5 [190]
CHO none 2.1 (AFM) or 7.9 (MT) ·10−5 4.9·10−4 [190]
NGC none 1.37·10−4 [193]
SBCl2 Grown on PLL 1.48·10−5 1.76·10−5
WM115 Grown on PLL 1.08·10−5 9.23·10−6
WM239A Grown on PLL 1.01·10−5 1.83·10−5
Weder et al. study Young’s Modulus [Pa] and (μ [mN/m])
SBCl2 Grown on PLL 194 Pa (4.8·10−4 mN/m) [205]
WM115 Grown on PLL 114 Pa (2.8·10−4 mN/m) [205]
WM239A Grown on PLL 247 Pa (8.4·10−4 mN/m) [205]
Table 2.1: Viscoelastic properties of cells measured under various conditions. Data
from red blood cells were collected by observing the suction of membrane tethers inside a
micropipette.[211] HB and CHO data were measured both by AFM and magnetic tweezers (MT)
nanotube formation and detachment.[190] NGC and vesicle data were calculated from the force
needed to pull one tether from the cell membrane. HEK, SBCl2, WM115 and WM239A cells
measurements were performed as described in section 2.2.5. Young’s moduli were measured by
pressing AFM tips to the top of cells.[205]
GUVs: giant unilamellar vesicles, SM: sphingomyelin, Chol: cholesterol, SOPC: 1-stearoyl-2-
oleoyl-sn-glycero-3-phosphatidylcholine, RBC: red blood cells, HEK: human embryo kidney,
HB: human brain tumor, CHO: Chinese hamster ovary, NGC: neuronal growth cone, PLL:
Poly-L-lysine
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stiffness as measured here by the membrane shear moduli of the different melanoma cell
types is directly related to the progress of the melanoma tumor state. WM239 cells could be
expected to be the most mobile and most deformable ones as they are the most invasive ones
among the three cell types investigated.[156, 214] Cells of this type circulate in the blood and
lymph systems and undergo severe deformations to penetrate tissues at remote locations
to establish metastatic nodules.[215] These nodules, once established, form a new cancer
cell colony, adapting the surrounding tissue to its growth needs. The creation of a dense
network of blood vessels and the resilience needed to resist to the compression consecutive
to its self growth explains the increased stiffness of the metastatic cells.[216] It appears that
growing metastatic nodules in a non-native environment exert a mechanical pressure on their
surrounding and, in return, are being compressed themselves; hence to survive, cells with the
most resistive mechanical abilities are selected over the softer ones and give to metastases
a more cohesive character. This may explain why the WM239A cells analyzed here display a
higher stiffness, as they have been extracted from a lymph-node metastatic tumor and were
no more in the blood circulation.
2.3.4 In-ﬂow immobilizing microchip
A speciﬁc chip has been designed for the in-ﬂow immobilization of cells to increase the
processing throughput of membrane probing. Inspired from the cell-docking microchip of
Skelley et al.[54], the microstructural element is placed in the centre of the main chamber of
the chip (Figure 2.15). It is designed to dock one single cell and a hole is left on the downstream
extremity to allow access to the membrane for pulling membrane nanotubes. After nanotube
back-relaxation, the cell is expected to be removed with the help of the optical tweezers, from
the dock and released in one of the two lateral streams, where a potential sorting step could
be implemented. After several trials, the PDMS docking element was observed to be a much
too sticky structure as it was impossible to move the cell out of the microﬂuidic channel once
it was in contact with the PDMS surface. Protective coatings such as BSA were applied with no
effect. A potential way to solve this challenge would be to add to the microchip a pneumatic
valve-controlled docking element to have a temporary immobilizing structure that can be
pushed in and out from a superior extra-thin PDMS layer as described by Araci et al.[217].
Another strategy could be to implement this microstructural element in a highly parallelized
microchip to immobilize a large number of cells at once and probe them on an automated
base. This would require a high precision in the docking of the cell to make it easy enough for
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the a programm to recognize the membrane edge to switch correctly on the trapping laser.
Substantial increase in complexity in microﬂuidic chip fabrication can now be achieved using
3D-printing.[218]
Figure 2.15: Cell immobilized in the microsized funnel-shaped PDMS dock. Cell is docked
into the PDMS microstructural element and a membrane nanotube can be pulled from it. Scale
bar = 10 μm.
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2.4 Conclusions and outlook
The results of our plasma membrane tube experiments are promising to be used in the future
in a microﬂuidic platform for the analysis of the progression state of tumors. The cancer cell
line WM115, originating from a tumor at a speciﬁc malignancy, could be discriminated from
other cells of the same type of cancer at different progression states. Yet some challenges
still have to be overcome to achieve relevant efﬁciency and reliability for clinical diagnostics.
Much higher throughput should be achieved by using a microﬂuidic chip that would be able
to process cells in suspension instead of having them attached to an immobile solid support.
Multiple external factors are known to disturb the membrane biophysical properties of the
plasma membrane, such as cell cycle or atmospheric pressure. This emphasizes the necessity
to performs such analyses in a tightly controlled environment and to record large amounts of
data, especially in the crucial goal of diagnosis.
Limitations arise from the success rate of the pulling of nanotubes, which is at the moment low.
We remain conﬁdent that automation of the process will provide a more precise positioning
of the optical trap on plasma membrane. Although the microﬂuidic chip fabricated from
PDMS did not fulﬁll all requirements for real application yet, it opened the way for future
improvements, for example towards either parallelization or on-demand activatable cell trap
with an lateral access to perform the pulling and back-relaxation measurements while the cell
remains still.
The beauty of the method lies in the fact that there is no need of binding the probed cell
to a bead or similar objects, which would inﬂuence the measurements of the biophysical
parameters. Cells remain unmodiﬁed and can withstand several nanotube pulls at predeﬁned
positions at the cell surface, thus opening the possibility to establish a non-invasive tomogram
of the viscoelastic properties of a cell surface. This also accounts for the vesicle extraction,
which would allow single cell selective analysis of membrane derived attoliter carriers from
predeﬁned locations in/on a cell, comparable to a sub-micrometer sized biopsy from a living
cell for further proteomic or functional analyses.
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Figure 3.1: Single-cell analysis with afﬁnity beads. A bead, prior deposited on top of a cell, is
internalized by phagocytosis. Protected from contact with cytoplasmic elements by a phagosome,
photoactivation of an added photosensitizer is used to break this protective layer. The bead can
then be extracted out of the cell with the help of an optical tweezer and the target molecules,
bound to the speciﬁc capturing coating of the bead, can be analyzed by ﬂuorescence microscopy.
Frontispiece of Small, volume 11, issue 22 (2015).
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3.1 Introduction
Rapid, accurate and relevant analysis of miniaturized biological samples is a central objective
of “lab-on-a-chip” concept, combining microﬂuidics and other miniaturized bioanalytical
methodologies to offer platforms enabling functional single-cell analysis.[219, 220, 221, 222]
In this context, two major hurdles have to be overcome: First, one or several molecular species
have to be speciﬁcally quantiﬁed in each cells. Second, a large number of cells has to be
processed to sample also rare cell phenotypes and to properly evaluate their functional signiﬁ-
cance. A good compromise between throughput, precision and complexity of the analysis is
difﬁcult to reach, if single-cell resolution is required. Flow cytometry is a powerful classical
method able to process thousands of single cells per second.[223] Despite the enormous
potential ﬂow cytometry offers due to a fully automated processing of the cells and a large
range of accessible wavelengths of excitation and emission, limitations arise from the need
for bright organic ﬂuorescent dyes as reliable probes.[224] This requires either molecules of
interest to be located at the extracellular membrane surface by post-translational labeling for
example using ﬂuorescently labeled antibodies, or to pre-treat cells by insertion of speciﬁc
labels in their cytoplasm before analysis. High contrast organelles and relatively large cellu-
lar elements can be observed during ﬂow cytometry analysis by light scattering without the
help of labels, but this application is limited to only a few cases.[225] Chemical cytometry,
represents a more generally applicable approach: a single cell is lysed, the target analyte
is separated from other contents in the cellular lysate, usually by capillary electrophoresis,
followed by speciﬁc detection and quantiﬁcation of the target analyte for example by laser-
induced ﬂuorescence.[226, 227] The deciphering of complex metabolic pathways requires to
determine picomolar concentrations inside cells; for a HeLa cell with an average volume of
3700 μm3[228], proteins have been quantiﬁed to range from 6000 to 20,000,000 copy number,
which corresponds to 2.7 nM and 9 μM respectively.[31] Of importance in this context is the
miniaturization of biological analysis processes into micro- and nanoscale operating plat-
forms, so called “lab-on-a-chip” devices. Their possibilities of high spatial and temporal ﬂow
control as well as the sensible shortening of analysis time make them promising biomedical
tools.
In the method described in this chapter, lab-on-a-chip concepts have been used to up-
concentrate the molecules of interest onto the surface and into pores of micron-sized silica
beads speciﬁcally coated with interacting molecules designed to capture analytes.[194, 53]
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Figure 3.2: Anatomy of a cell. The organizational complexity of a cell, containing numerous
organelles and displaying heterogenous distribution of cellular components, makes it a chal-
lenge to analyze and understand the various biochemical processes occurring in the smallest
individual unit of living organisms. Image from [229].
Capturing target analytes circumvents the dilution issue appearing in numerous other single-
cell methods, which rely on cell lysis. Concentrating the target analyte on a bead makes it
possible to transfer the bead together with the analytes with minimal loss to different places in
the microﬂuidic chip. Capturing cytoplasmic molecules or intracellular components however
requires to access the cytoplasm of single cells. Small objects (such as microbeads) inserted
into the cytoplasm are typically captured by the cell by endocytosis or phagocytosis.[230, 231,
232] Advantage has been taken of this process by dispersing a suspension of microbeads over
cells and waiting overnight to let them be internalized into cells via endocytosis. Silica beads
of 3 μm in diameter have been selected as they are easily phagocytosed.[233] Furthermore,
beads of this size are very well suited for microscopic manipulation and observation and do
not disturb signiﬁcantly the cell after integration. Silica beads have a higher refractive index
than most internal components of cells, which makes it easier to observe them in bright ﬁeld
microscopy and more convenient to trap them optically.
Once functionalized beads have been internalized into the cell, they remain protected from di-
rect contactwith the cytoplasmby integration into small closed containers called phagosomes.[234]
In order to access the target analytes, the beads must be released from the phagosomes. The
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most appealing method for this speciﬁc application happened to be photochemical inter-
nalization (PCI), chosen for its membrane destabilization capabilities.[235, 236] Here we
used the photosensitizer TPPS2a as a membrane destabilizing element to liberate the beads
from their enclosing phagosomal membrane. Upon irradiation at 405 nm, reactive oxygen,
mainly singlet oxygen[237], is produced by TPPS2a , which causes the surrounding phago-
somal membrane to get damaged allowing to access the beads. PCI has been used so far
to release naturally internalized molecules from endosomes such as nucleic acids, proteins
and therapeutic drugs.[236] In our present case, analytes have to reach and bind the capture
agents located on the bead surface and in the bead pores and to be up-concentrated. Pores in
the microbeads allow binding a high concentration of analytes; furthermore, high density of
capture agent on the microbeads promotes rebinding of the analyte after dissociation, which
tends to keep target analyte trapped on the bead in a similar way as in the case of afﬁnity
chromatography. Concentrating analytes onto a bead also prevents unwanted adsorption on
the walls of the microchannel. As a single cell may incorporate several beads, cells should
be prior sorted and only the ones containing a single liberated bead should be analyzed to
keep single-cell resolution. Optical trapping has been used here to analyze in situ a selected
bead by ﬂuorescence microscopy. The developed procedure is described in detail in section
3.2.5. Fluorescence microscopy is a fast and reliable analytical technique that can be imple-
mented together with optical tweezers on the same setup, as described in section 2.1.3. In situ
measurements prevent loss of analyte molecules related to transfer into an external analysis
unit.
This method may ﬁnd applications in the diagnostics ﬁeld, especially for cancer diagnosis.
As cancer is characterized by uncontrolled gene product expression, capability to detect key
molecules or proteins is crucial for the selection of the most efﬁcient treatment of cancer.[238]
Highlighting of speciﬁc molecules is a great indicator for discrimination of drug targets in case
of administration of highly powerful chemotherapy agents.
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3.2 Experimental
3.2.1 Preparation of mixed Ni-NTA-antibody functionalized beads
Silica beads (Sicastar 3 μm, Micromod) coated with protein A and Ni-NTA are suspended in
PBS at a concentration of 109 particles per ml. A 15 μl solution of 1 mgml polyclonal anti-RFP
antibody against red ﬂuorescent protein (ab28664, Abcam) is added to 250 μl suspension of
beads and the suspension is incubated for 1 h at room temperature under gentle agitation. Free
antibodies are removed by washing three times with 0.2 M sodium borate at pH 9.0, afterwards
the beads are resuspended in 250 μl borate buffer. 1.25 mg of dimethyl pimelimidate is added
to cross-link bound antibodies and protein A. After 30 min incubation at room temperature
under gentle agitation, ethanolamine is added to a ﬁnal concentration of 0.2 M to quench
excess dimethyl pimelimidate. After another 2 h of incubation, the beads are washed three
times with PBS and suspended in PBS in a ﬁnal volume of 250 μl. The beads are stored at 4°C
and are ready for use.
3.2.2 Cell transfection and bead internalization
HEK cells are grown on 8-well dish (Lab-Tek II chambered coverglass, Nunc) in a 37 °C
incubator. One day after splitting, they are transfected with the particular plasmid following
either the standard procedure of Lipofectamine mediated transfection (Lipoefctamine 2000
Transfection Reagent, Invitrogen) or according to a calcium phosphate transfection protocol.
Second day after splitting, a suspension of functionalized beads (to a ﬁnal concentration of
4 ·105 - 2 ·106 beads par ml) together with photosensitizer TPPS2a (PCI biotech, to a ﬁnal
concentration of 0.7 μgml ) are added on top of the cells (Figure 3.3). After another 24 h of
incubation at 37 °C, the cells have internalized the beads by phagocytosis and are ready for
use in further experiments.
3.2.3 Phagosomal escape
Cells containing both TPPS2a and phagosome internalized beads are exposed to 405 nm light
(laser pointer) at a power of approximately 5 mWcm2 for 5 min. To optimize the illumination, the
cell-containing dish is placed on top of a reﬂecting surface (aluminum foil). Cells can then
be suspended in PBS for microﬂuidic analysis or observed directly in the 8-well dish under
microscope.
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3.2.4 Cell trapping
After illumination, cells are detached from the culture surface and suspended in PBS. They are
injected with a 10 μl syringe (Hamilton) in the microﬂuidic system to the microchip (Figure
3.4). The observation setup is described in detail in section 2.1.3. The ﬂow rate is adapted
to the needs of the experiment, usually at 0.1 μl, which is optimal to quickly discriminate
dead cells from healthy ones and to select a cell comprising one single afﬁnity bead. Cells
are injected in a channel of 100 μm wide and 50 μm high merging with the lysis and analysis
channels to form together a channel of 400 μm width. In a typical protocol, a cell containing
one bead is immobilized in the optical trap. Since the trapping force is proportional to the
difference in refractive index between the medium and the object [65] and the refractive index
of the silica bead is higher than the rest of the cell (silica bead: 1.45 [239], cell membrane: 1.40
[240], PBS: 1.34 [241]), the bead is trapped in the laser focus. As it is tightly embedded in the
internal cellular structure, the whole cell moves as the optical trap is displaced.
3.2.5 Cell analysis
Once trapped, the cell of interest is dragged to the lysis channel, where buffer containing 0.1%
SDS (Sigma) is ﬂowing. The cell lyses in a few seconds and all its constituents are carried away
by the buffer ﬂow, leaving only the bead and all what is attached on it. The bead is moved
further to the analysis channel where a detection agent can be added if needed. Fluorescence
measurement of the probe molecules is performed to detect and quantify the amount of
protein of interest captured by the bead.
Figure 3.3: Single-cell cytometry: internalization of beads into cells. After internalization of
beads, cells are exposed to 405 nm light inducing phagosomal TPPS2a mediated disruption,
giving access of the beads to the cytoplasm.
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Figure 3.4: Single-cell bead analysis. After the cells have been exposed to UV light, they are
injected into the microﬂuidic chip where the internalized bead, and in turn the cell, gets trapped
by the optical tweezer. The immobilized cell is dragged to the lysis channel where a stream of
detergent solution dissolves the plasma membrane and organelles of the trapped cell to leave
in the optical trap only the bead with bound protein analyte. The bead is then dragged to the
analysis channel. If the target protein is ﬂuorescent by itself, it can be directly detected and
quantiﬁed by ﬂuorescence microscopy; if not, a ﬂuorescent antibody or a selective ﬂuorescent
ligand provided by the analysis channel makes it detectable and quantiﬁable.
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3.3 Results and discussion
3.3.1 Phagocytosis in multiple cell lines
Although phagocytosis is a process belonging principally to the behaviour panel of phagocytes,
other cell types are capable of absorbing external elements in a less aggressive and active
fashion. 3 μm beads have been deposited on top of several cell lines, HEK cells, BHK cells,
MCF7 human breast cancer cells, MIN6 pancreatic beta cells, SBCl2 human radial growth
phase melanoma and WM239A lymph node metastatic cells of human skin melanoma, to
observe their ability to internalize into the cells mediated by scavenger receptors. After
overnight incubation, 2 mM eGFP-His10 was added to the cell medium, so that the non-
internalized beads bind massively the green ﬂuorescent protein. 12 hours are necessary to
observe good phagocytosis yields as no signaling molecule mediates the process, which is
only directed by scavenger-type receptors.[242] Only beads protected intracellularly did not
display green ﬂuorescence (Figure 3.5). As eGFP-His10 does not penetrate the cell, beads
inside phagosomes cannot bind it. It has also been shown that once internalized, beads are
wrapped inside endosomal vesicles and are not in contact with the cytoplasm of cells.[194]
Hence we consider as that phagocytosis is a cellular process that can be used reliably in our
method for the internalization of afﬁnity beads.
3.3.2 Capture of a single analyte
The experiments on beads with a single type of coating and the capture of a single analyte were
designed in collaboration with Michael Werner and Raghavendra Palankar.[194, 53] Brieﬂy it
has been demonstrated that it was possible to insert a ﬂuorescent bead coated with Ni-NTA
groups into HEK cells by phagocytosis in combination with TPPS2a , a photosensitizer that lib-
erates singlet oxygen molecules upon 405 nm light irradiation. Once phagocytosed, the beads
are liberated from the lipid capsule with a short exposure to a 405 nm laser and can access
the cytoplasm of the cell. Histidine-tagged eGFP binds to the bead, which is then extracted
from the cell inside a microﬂuidic chip. The presence of eGFP can be detected by ﬂuorescence
microscopy and the ﬂuorescence signal is proportional to the initial concentration of eGFP in
the cell.[194]
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Figure 3.5: Phagocytosis of Ni-NTA coated silica beads bymultiple cell lines. Beads deposited
on top of (A, B) BHK cells, (C, D) MCF7 human breast cancer cells, (E, F) MIN6 pancreatic
beta cells, and (G, H) SBCl2 human melanoma cells. To distinguish internalized from non-
internalized beads, eGFP-His10 was added to the cell medium prior to analysis by confocal
microscopy. Accordingly, beads not internalized by cells were able to bind eGFP-His10 in the
extracellular medium. (A, C, E, F) Transmission micrographs of the different cell types with
internalized and non-internalized silica beads. (B, D, F, H) Corresponding confocal ﬂuorescence
micrographs facilitating the discrimination between internalized beads (non-ﬂuorescent) and
non-internalized beads (green ﬂuorescent). Scale bars: 15 μm.
51
Chapter 3. Single-cell analysis with afﬁnity beads
3.3.3 Simultaneous capture of two orthogonal analytes
In order to demonstrate the possibility to multiplex the number of proteins that can be
detected using single-cell analysis with afﬁnity beads, we have chosen two orthogonal capture
systems allowing to bind two spectrally distinct autoﬂuorescent proteins: eGFP[243] and
mCherry.[244] eGFP is expressed with a N-terminal 10-histidine tag, hence Ni-NTA is used
on the bead as the ﬁrst capturing agent as it has a natural afﬁnity for nickel ions.[245] As
mCherry does not bear a speciﬁc tag, we have chosen a capturing antibody (ab28664, abcam)
which speciﬁcally bind mCherry but does not bind eGFP. 3 μm beads are used comprising
a mixed coating of Ni-NTA groups and protein A to which various proteins can be attached.
After completing the coating, the beads together with TPPS2a are spread over HEK cells
expressing simultaneously tagged eGFP and mCherry. After 12 hrs incubation, many cells
contain at least one non-ﬂuorescent bead, indicating that the bead is indeed inside the cell
and protected from direct contact with the ﬂuorescent cytoplasm enclosed in a phagosome
(Figure 3.6, top line). The cells are illuminated with 405 nm laser light to promote phagosomal
escape of the beads. It is not clear yet whether the phagosomes are entirely disrupted or if
they are only destabilized to allow permeability of proteins and other solutes through their
membrane, although evidences in section 4.3.3 seem to indicate permeability increase at
such low concentrations of TPPS2a . After illumination, we observe a gradual increase of the
ﬂuorescence signal on the capturing beads. 3 minutes are needed for mCherry to reach the
maximum ﬂuorescence level, whereas 10 minutes are necessary for maximal binding of eGFP.
Both proteins are bound simultaneously on the beads (Figure 3.6, bottom line).
After illumination, cells containing beads with both mCherry and eGFP are suspended into
PBS and injected into the microﬂuidic chip for bead isolation and ﬂuorescence detection.
A cell is immobilized by the optical trap via its internalized bead (Figure 3.7, top line). The
cell is then dragged into the lysis channel to be dissolved by detergent, leaving only the bead
and the captured proteins in the optical trap. The bead is then transferred to the analysis
channel where the presence of eGFP and mCherry is observed by ﬂuorescence imaging. The
whole process takes approximately 30 seconds to 1 minute. This demonstrates that the two
orthogonal proteins can be bound on mixed functionalized beads and that more than two
simultaneous binding events might be technically feasible, with the only limits that the signals
must be distinguishable. The multiplexing potential thus relies on the surface concentration
capability as well as on the ﬂuorescence properties of the target analyte.
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Figure 3.6: Beads comprising a double-coating inside a HEK cell before and after UV illu-
mination. A bead was deposited on top of a cell and absorbed by phagocytosis, together with the
photosensitizer TPPS2a. Before UV illumination (top line), none of the cytoplasmic ﬂuorescent
proteins is detected on the bead surface. After 5 minutes of illumination at 405 nm, and further
10 minutes incubation (bottom line), both eGFP (middle column) and mCherry (right column)
have bound to the bead. Scale bar = 10 μm.
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Figure 3.7: eGFP andmCherry captured on an optically trapped bead, before (top) and after
(bottom) lysis of the surrounding cell. The bead is coated with both Ni-NTA and anti-mCherry
antibody captured simultaneously and efﬁciently the two proteins from the cytoplasm of a cell.
After the cell is transferred into the lysis channel, the entire cell is dissolved by detergent and the
remaining bead is moved into the analysis channel for ﬂuorescence readout. The presence of
both eGFP and mCherry indicates that a bead can capture two different sorts of analyte using
orthogonal capturing agents. Scale bar = 10 μm.
3.3.4 Maximal imidazole concentration in analysis buffer
The binding of His-tagged proteins to Ni-NTA groups is based on the speciﬁc interaction of im-
idazole groups with multivalent transition metal ions.[246] Taking advantage of the chelating
effect, the afﬁnity to polyhistidine sequences is superior over imidazole monomers.[247] Typi-
cally decahistidine tags on proteins are optimal for binding to Ni-NTA groups on microbeads.
The addition of small quantities of monomeric imidazole in the washing buffer removes those
molecules which are poorly bound to the afﬁnity bead surface while not disturbing these
which are speciﬁcally bound to polyhistidine groups.[248] This is especially true in the case of
using a secondary molecule to characterize the presence of the initial captured protein. As we
want to keep as much speciﬁc binding of the protein of interest on the afﬁnity beads, our goal
is to ﬁnd the upper limit concentration of imidazole at which the ﬂuorescence intensity of
eGFP-His10 immobilized on the bead is not decreased compared to imidazole-free conditions.
To approximate the maximal concentration of imidazole in solution that would not interfere
with the binding of His-tagged eGFP, beads coated with Ni-NTA groups were immersed in
solution of 100 nM of eGFP-His10 in PBS. Imidazole added in separate compartments to
concentrations varying from 1 to 50 mM, then followed by an overnight incubation to give
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Figure 3.8: Fluorescence intensity of eGFP-His10 on beads vs free imidazole concentration
in bulkmedium. As the concentration of free monomeric imidazole in the bulk increases, the
recorded ﬂuorescence intensity (arbitrary units) of eGFP-His10 bound to capturing beads is
decreasing. Enhanced resolution (insert, top right corner) shows that the maximal imidazole
concentration at which eGFP signal is not altered is 1 mM.
enough time to the system to reach equilibrium. eGFP ﬂuorescence is recorded by confocal
ﬂuorescence microscopy. As we observed that the ﬂuorescence intensity of bead-bound eGFP
started decreasing around 1mM of imidazole, we reﬁned the observed concentrations from
0.1 to 2 mM with the same procedure. A clear decrease in ﬂuorescence of eGFP bound on
beads was detected at 1 mM imidazole, while the ﬂuorescence signal remained constant
up to 0.75 mM imidazole (Figure 3.8). We thus established the maximum concentration of
free monomeric imidazole that can be used in buffers during the experiments of secondary
detection without disturbing the binding of eGFP to the afﬁnity beads being 0.75 mM.
If the binding partners were as in our case polyhistidine and Ni-NTA groups, the most suitable
molecule for preventing non-speciﬁc interactions is imidazole. In the case of other capturing
agents, a coherent choice of non-speciﬁc interaction blocker has to be found in order to
minimize false positives and to better correlate the labeling molecule with the analyte of
interest.
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3.3.5 Correlation of eGFP ﬂuorescence on the bead with eGFP concentration in
the cell
The correlation between the ﬂuorescence intensity of eGFP-His10 bound to Ni-NTA coated
beads with the concentration of eGFP in surrounding buffer solution has been established
elsewhere by immersing beads in a solutions of different eGFP-His10 concentrations.[194]
(supplementary information) This works well as a proof of concept, however it does not
reﬂect the reality of a conﬁned, material-limited and crowded intracellular environment.
The establishment of a precise correlation between in-cell eGFP concentration and on-bead
eGFP ﬂuorescence is an absolute necessity if quantiﬁcation of analytes should be achieved.
Since the numerous trials to perform UV phagosome liberation in microﬂuidic chips with
beads immobilized in the optical trap did not give satisfactory results, notably because of ﬂow
instability, enhanced photobleaching or microexplosions of microscopic air bubbles in the
microchannel, the measurements are ﬁnally performed in a traditional culture dish with a
ﬂuorescence confocal microscope.
To proceed, we cultured HEK cells in 1 cm2 compartments and transfected them as described
in section 3.2.2 with peGFPN1 plasmids (Clonetech). After incubation varying from a fewhours
to 4 days, beads are dispersed over the cells with TPPS2a and incubated at 37 °C overnight,
bringing the total incubation time for eGFP-His10 production to 1-5 days. A large range of
incubation times increases the range of resulting intracellular concentrations of eGFP. Finally
the culture medium is replaced by a PBS solution containing 1 μM eGFP-His10 that serves
as internal standard for evaluation of the cytoplasmic concentration of ﬂuorescent protein
in cells. After a ﬁnal incubation time of 90-180 minutes, microscopic images of the cell
population are recorded to ﬁnd those individual cells which have internalized only one single
afﬁnity bead inside a non-damaged phagosome (Figure 3.9, left column, arrows). The cells
are then illuminated with 405 nm light for four minutes. Several minutes after illumination,
microscopic images are recorded again to observe the ﬂuorescence intensity of eGFP-His10
on beads captured by Ni-NTA groups on the beads. It is important to note that only cells
comprising a single bead having undergone photochemical liberation from phagosome are
taken into consideration (Figure 3.9, right column, arrows).
Figure 3.10 shows a linear correlation between the eGFP ﬂuorescence intensity on individual
beads and the free intracellular eGFP concentration ranging from 1-25 μM. The ﬂuorescence
intensity of eGFP-His10 bound on beads has been translated into a virtual equivalent concen-
56
3.3. Results and discussion
Figure 3.9: Cells expressing eGFP-His10 with beads inside phagosomes before and after UV
illumination. Cells expressing eGFP-His10 having phagocytosed Ni-NTA-coated beads. The
beads were resting inside of phagosomes and thereby were protected from direct contact with
cytoplasmic content (left column, arrows). After UV illumination, the phagosomes are destroyed
allowing access of cytoplasmic eGFP-His10 to the Ni-NTA groups on the beads. Beads become
ﬂuorescent in parallel to decreasing intensity of eGFP ﬂuorescence of the cell cytoplasm. Only
cells containing one single bead having gone from dark to bright state have been considered
(right column, arrows).
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Figure 3.10: Fluorescence intensity of eGFP-His10 on beads vs intracellular concentration
of eGFP-His10. Fluorescence intensity of eGFP-His10 bound to afﬁnity beads versus the con-
centration of ﬂuorescence intensity of cellular eGFP-His10 prior photochemical opening of the
phagosomes. The linear relation allows quantiﬁcation of the eGFP content of a cell from the
eGFP ﬂuorescence bound to a bead.
tration of free eGFP by dividing the recorded signal by the surrounding background signal
displaying the ﬂuorescence of 1 μM of free eGFP. This correlating factor can be applied to other
systems. In our case, the correlation coefﬁcient is 2.27, which is the average ratio between the
ﬂuorescence of the bead and the ﬂuorescence of the cell before the bead binds eGFP-His10.
Thismethod of calibration is however only valid for ﬂuorescent analytes. Precise calibration for
non-ﬂuorescent proteins would require to work in parallel with other quantitative methods.
3.3.6 Detection of an analyte on microbeads using a secondary antibody
The procedures described in sections 3.3.2 and 3.3.3 are only valid for analytes displaying
intrinsic ﬂuorescence. For non-ﬂuorescent proteins, it is necessary to label the protein with a
suitable probe to achieve proper detection. Several options are available with different degrees
of complexity. Mass spectrometry analysis of the beads would require mass tags on the
target protein.[249, 250, 251] For this approach, the precision, throughput and multiplexing
possibilities are actually very promising. However, the use of mass spectrometry associated to
our method would substantially increase the complexity of our microﬂuidic platform as the
beads must be transported outside of the chip for analysis. This causes problems, such as the
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Figure 3.11: Extraction of a bead from a suspended cell followed by the addition of ﬂuores-
cent antibody. Left: a suspended cell expressing eGFP-His10 and containing a Ni-NTA-coated
bead that has already bound eGFP after having previously been illuminated by UV light. Middle:
eGFP-His10 ﬂuorescence of the bead after lysis of the cell. Right: Labeling antibody ﬂuorescence
on top of eGFP-His10 molecules bound to the Ni-NTA groups of the bead. Scale bar = 10 μm.
potential loss of beads or the loss of material captured on the bead. The implementation of
micro-droplet generation[252] would also be an interesting alternative, however, associated
with very complicated handling in the absence of full automation of the system.
A much simpler alternative is based on the use of a secondary binding element, typically an
antibody or a ligand, comprising a ﬂuorescent probe that can be detected by ﬂuorescence
microscopy. This approach is chosen here to demonstrate its feasibility to allow rapid and
direct in situ observation of the selected analyte. Its implementation is straightforward as the
optical tweezer setup is integrated in a ﬂuorescence microscope and because many versatile
ﬂuorescent probes for labeling antibodies are commercially available. To demonstrate the
feasibility of the approach, we have chosen to use Ni-NTA beads (Sicastar 3 μm, Micromod) to
capture histidine tagged eGFP from transfected HEK cells and to further mark eGFP with a red
ﬂuorescent anti-eGFP antibody (ab6660, abcam). As both the target protein and the antibody
are ﬂuorescent, it is possible to determine whether the technique is suitable for quantiﬁcation
of the target protein by quantiﬁcation of the antibody, as the two different ﬂuorescence signals
deliver independent means for quantiﬁcation of the target protein on the bead.
To keep the system as simple as possible, we applied the ﬂuorescent antibody in the analysis
channel of the microchip at a relatively low concentration (10 μgml ). The freshly extracted
eGFP-His10 comprising bead from the cell quickly accumulates the antibody probe to reach
a maximal signal after about ten seconds. Exciting the bead at 488 and 543.5 nm yielded
ﬂuorescence signals of both target proteins eGFP-His10 and the antibody probe labelled with
Texas Red, allowing comparison of both signals. Figure 3.12 shows a linear correlation (t-
test, p-value = 1.2 ·10−5) between the concentration of intracellular eGFP-His10 measured
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Figure 3.12: Correlation between the ﬂuorescence signal of bead bound ﬂuorescent anti-
GFP antibodywith the intrinsic ﬂuorescence of bead bound eGFP-His10. Fluorescence of the
Texas-red-labeled anti-GFP antibody against the concentration of intracellular eGFP-His10 cal-
culated from the ﬂuorescence intensity of eGFP bound to the bead after cell lysis. The correlation
is signiﬁcant (t-test, p value = 1.2 ·10−5).
from the ﬂuorescence intensity of eGFP bound and the bead after cell lysis (Figure 3.12),
demonstrating the potential to quantify analytes with ﬂuorescently labeled binding molecules
such as antibodies. This is a proof of concept that soluble analytes can be collected from a
single cell onto an afﬁnity bead and subsequently analyzed by ﬂuorescence microscopy after
a short on-chip labeling step following the lysis of the cell.
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3.4 Conclusion and outlooks
Up until now, rapid cell lysis by crossing microﬂuidic streams was restricted to the separation
of large,micrometer- sized analytes such as bacterial chromosomes.[253] Ourmethod is princi-
pally amenable for investigating any type of cytosolic analyte. In contrast to prior microﬂuidic
single-cell analysis methods involving cell lysis and therefore dilution of intracellular species
over several orders of magnitude, our method comprises target analyte enrichment on the
bead surface. This is due to the strong interaction between the analyte and the capture agent,
and the high local concentration throughout the volume of the beads. Consequently, rebinding
dominates over dissociation and escape. A similar situation is present during afﬁnity-column
puriﬁcation of proteins using porous beads with capture groups, where washing steps can be
performed with virtually no loss of bound material. Another advantage compared to other
single-cell analysis methods is that analyte binding in individual cells can be executed simulta-
neously for a large number of cells. Given this high degree of parallelization for target analyte
binding, the throughput of the method is mainly determined by the bead extraction and anal-
ysis procedure, which for our present experimental conﬁguration is at the order of 1–2 cells
per minute. This low throughput is determined by the fact that all experimental steps starting
from optical trapping of a bead-comprising cell to ﬂuorescence imaging of the extracted bead
were conducted manually. The entire workﬂow, however, could be readily automatized as
has been demonstrated for other cases on optical trapping.[254, 255] For such conditions
the throughput would be mainly limited by the time required for cell lysis. Here, cell lysis
occurred in less than 3 s enabling a potential throughput of about 20 cells per minute. Faster
methods, such as optical[256] or electrical lysis[257] proceeding on a millisecond timescale,
might further increase the throughput considerably.
Taking advantage of recent technological progress in the fabrication and manipulation of
microscopic particles we here developed a novel integrated concept for the chemical analysis
of single cells. Although still at an early stage we proved that our method enables extraction
and analysis of speciﬁc intracellular contents from individual cells, at reasonable throughput
and virtually no sample dilution. Therefore, this method has the potential to evolve into
a sensitive platform for investigating fundamental aspects of cellular physiology and into
a powerful single-cell technology for routine applications in molecular diagnostics. A few
limitations of this method, intrinsic to its basic principles, require attention before selecting
it for a speciﬁc application. Non intrinsically ﬂuorescent analytes require a prior calibration
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strategy to be able to faithfully quantify them with a labeled antibody. Natural phagocytosis of
the afﬁnity beads is a prerequisite to reduce stress the target cells; hence this could become a
time-limiting step once the analysis procedure is fully automated.
Full automation of the lysis-detection process would increase the rate of analysis to higher
throughput, with cell lysis and labeling procedure as time-limiting steps. Up to 20 cells per
minutes could be processed in a single analysis units, meeting with a higher versatility the
rates of the actual fastest methods available.[44] Full automation opens the way to a massive
parallelization that would furthermore increase the throughput up to those of conventional
ﬂow cytometry. Our method offers novel opportunities in single-cell diagnostics for diseases
affecting metabolism or protein expression to identify and quantify biomarkers with the
perspective to provide to patients personalized therapies.
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4.1 Introduction
4.1.1 Extracellular vesicles
Biological cells have a wide variety of communication tools to transfer information to one
another. They can communicate with their direct neighbours through gap junctions or via
synaptic connections [258, 259, 260, 261], with cells of their close vicinity by diffusion of small
chemical molecules or ions [262, 263, 264] and with partners located at much larger distances,
over the range of the whole organism with more complex biologically active molecules, with a
long lifetime in the circulation of blood.[265, 266, 267] As these communication procedures
are the result of million years of evolution, one expects them to have reached a very high level
of efﬁciency. For example hormones can induce dramatic changes in an organism at low blood
concentrations thanks to a very powerful signaling machinery.[268, 269] Another signal and
material transmission machinery used by organisms are extracellular vesicles (EVs). EVs are
small vesicles excreted by cells and contain various cellular components in their lumen as well
as on their surface.[144] They transport cargo of genetic material and can propagate diseases
such as cancer.[270, 271, 149]
Extracellular vesicles, ﬁrst observed in 1996 [272], are proteoliposomes ranging 50 to 1000
nm that are excreted by nearly all eukaryotic cells. Thought at ﬁrst having no other biological
function than transporting cellularwaste, theywere recently shown to play an important role in
intercellular communication. They have been often referred as apoptotic bodies, the vesicular
structures with a signaling role created by cells undergoing programmed cell death.[273] But
then it was found that they are produced also by many healthy cells. EVs have two main
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Figure 4.1: Formation of two different kinds of extracellular vesicles: microvesicles and ex-
osomes. Microvesicles are shed from the surface of the cell, with a membrane composition
directly issued from the plasma membrane of the cell and an internal compartment originating
from the cellular cytosol. Exosomes are formed by internal budding inside multivesicular bodies.
Smaller in size than microvesicles, they are excreted when their endosome container fuses with
the plasma membrane and liberates them in the extracellular medium. Image taken from [144].
origins (Figure 4.1). Microvesicles are formed by exocytotic budding of the plasma membrane.
Their diameter ranges from 0.1 to 1 micrometer. Exosomes are smaller-sized vesicles, with a
diameter between 50 and 200 nm. They are formed by a budding process insidemulti-vesicular
bodies and are released by cells when the surrounding endosome fuses with the plasma
membrane (Figure 4.1). Themembrane of exosomes is rich in various transmembrane proteins.
Unlike their membrane of origin, exosomes appear to be strongly enriched in transmembrane
proteins of the tetraspanin family [274], which serve as markers of choice for detection or
immobilization of exosomes. The membrane of exosomes comprises a high proportion of
saturated and mono-unsaturated lipids, as well as, in some cases, cholesterol.[275] Markers
at the surface seem to direct exosomes towards targeted cell types[276, 277] using different
mechanisms, depending both on the exosome and on the recipient cell; permanent docking,
fusion with the recipient membrane or endocytosis are possible.[278]
EVs have been reported to transfer information in numerous various biological processes. For
example, EVs harvested from mouse embryonic stem cells have been shown to increase the
survival and growth of hematopoietic stem cells to preserve the pluripotency of the cells.[279]
Vesicles also exhibit healing properties; rats, to which acute post-ischemic injuries have
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been inﬂicted to kidneys, showed a remarkable recovery after intravenous injection of EVs
derived from human mesenchymal stem cells.[280] Furthermore, it seems in this case that
EVs prevented kidneys from suffering of chronical diseases after acute injury. The action of
blood circulating EVs derived from monocytes and macrophages has been highlighted to
help coagulation by selectively fusing with activated platelets and activating a coagulation
factor.[281] Meanwhile, EVs are also implied in the transmission and propagation of impairing
conditions from diseased to healthy cells.
EVs help to transmit characteristics of certain cancer cells to surrounding cells in diverse
ways.[282] For example, oncogenic proteins transported by EVs can affect the biological
function of surrounding cells. Brain gliomas use this mechanism to transfer oncogenes
produced by a small subset of cells to neighboring cells to foster the growth of the tumor.[283]
EVs also function as an important cell-to-cell transport system for genetic material. mRNA
and miRNA have been found in microvesicles isolated from glioblastoma cells.[284] mRNA
of microvesicles has been shown to be translated in the receiving cell which initially was
lacking the corresponding protein. Since oncogenes are expressed in a very abundant way,
they are prone to be contained in EVs that are disseminating around their cell of origin, hence
propagating genetic material for the production of oncogenic proteins. These features make
EVs a very efﬁcient tool for the so-called “horizontal” propagation of cancer, where proteins
and genetic material are exchanged between cells as a driving force of the progression of
tumors. Healthy cells suffer from a prolonged exposition to EVs produced by nearby malignant
tumors, as they inevitably absorb them and integrate their content. Biological functions
are directly altered by the transferred proteins and unwanted genetic material can alter the
proteome of the recipient cell. Long-term exposition can lead to cell reprogramming or
cell death.[285] Among transferred proteins, growth factor membrane receptors are found to
modify the biology of neighbouring cells by artiﬁcial activation of transforming pathways.[286]
Numerous pathways of oncogenic proteins are concerned with EV transmission to close-by
cells.
Cancer-derived EVs are present in body ﬂuids of patients, especially in blood, were they can
reach concentrations as high as 1010 EVs per ml. This abundance added to the relatively
high number of characteristic proteins or pieces of genetic material make them candidates of
choice for the detection and speciﬁcation of cancer.[284] EVs can be isolated by a combination
of ultracentrifugation, ultraﬁltration and size-exclusion chromatography.[287, 288]
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4.1.2 Liposomes as carriers of material and information to cells
For several year, research has focused on the elaboration of spherical lipid vessels to deliver
chemicals and drugs in the organism.[289, 290, 291] If regular liposomes have a poor efﬁciency
in delivery, selectivity, life-time and or mechanical resistance, substantial improvements can
be achieved by chemical or biological modiﬁcations. Circulation life-time can be improved by
adding of protective molecules such as long polymers preventing access of degrading enzymes
to liposomes circulating in blood and preventing their aggregation.[292, 293] Targeting a
speciﬁc cell type with artiﬁcial liposomes can be achieved to a certain extent by including
afﬁnity molecules, such as antibodies or ligands, on the outer layer.[294, 295] The delivery of
vesicles to the target cell can be optimized by attaching fusogenic molecules to the vesicle
surface. These molecules can be fusogenic proteins, such as SNAREs, which carry the natural
fusion capabilities to mediate actively or increase the fusion probabilities of the liposomes
with targeted cells.[296, 297] Objects as complex as living cells have been shown to fuse under
the action of SNAREs. The fusion is operated by speciﬁc interaction of v-SNAREs (vesicular
SNAREs) with t-SNAREs (target membrane SNAREs), two complementary sets of speciﬁc
partners respectively located on the vesicle and the target membrane, which actively wrap
around each other. This causes the vesicle to come closer and closer of the membrane up to
fusion of both entities.[298] Positively charged artiﬁcial lipids, such as DOTAP (1,2-dioleoyl-3-
trimethylammonium-propane chloride) or DDAB (dimethyldioctadecylammonium bromide),
can be incorporated in the lipid membrane of liposomes to take beneﬁt from the negatively
charged plasma membrane of cells to increase the fusion capabilities of the liposomes, with a
fusion process based on the attraction of opposite electrical charges.[299, 300] Transfection
methods such as Lipofectamine are based on the spontaneous attraction of positively
charged charged lipids with negatively charged genetic material.[301, 302]
EVs are body’s own specialized way to diffuse genetic information from cell to cell with
potentially both high speciﬁcity and fusogenic abilities. Investigating them for transport of
speciﬁc exogenous material into targeted cells and transforming them for increased targeting
and fusion capabilities is an opportunity to hijack nature for medical purpouse.[278, 303] In
this chapter, we explore the ﬁrst steps towards the use of EVs with enhanced fusion capabilities
encapsulated in giant vesicles as potential curing agents. From the modiﬁcation of the lipid
composition of EVs to the different methods for triggering the releases of proteoliposome as
large as 250 nm, the ﬁrst steps in the direction of a potentially powerful healing method are
explored.
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4.2 Experimental
4.2.1 Isolation of extracellular vesicles
Extracellular vesicles were isolated and puriﬁed as described by Wyss et al.[288]. Brieﬂy, par-
ticular cells are cultured in 150 ml plastic tissue culture ﬂasks (TPP) up to surface conﬂuence
in standard culture medium supplemented by NBCS and antibiotics. The culture medium
is then replaced by NBCS-free medium and incubated for two days. The culture medium is
centrifuged at 300 g to pellet cell debris and the supernatant is passed through a 0.2 μm ﬁlter.
The ﬁltrate is concentrated in a ultracentrifugation concentrator with a 100 kDa cutoff. The
concentrate is passed through a 0.2 μm centrifugal ﬁltration unit, then through a Sephacryl
S-500 HR (GE Healthcare Life Sciences) size-exclusion chromatography column with PBS as
eluent. The fractions containing EVs are collected and if necessary frozen in liquid nitrogen
for further use.
4.2.2 Modiﬁcation of the lipid composition of extracellular vesicles
Lipid composition of EVs is modiﬁed according to a protocol described elsewhere.[202] The
corresponding lipids dissolved in chloroform are transferred into a 1 ml glass bottle and dried
under a ﬂow nitrogen and 1 h vacuum. The lipid ﬁlm is solubilized in ethanol by strong
stirring. A small volume of lipid solution (typically a few microliters) is added to the puriﬁed
EV dispersion to a ﬁnal concentration of 10 μg/ml and incubated under gentle shaking for 30
minutes. Under these conditions, the exogenous lipids are spontaneously inserting into the
membrane of the EVs. The modiﬁed EVs are then ready to be used.
4.2.3 Insemination of mammalian cells with extracellular vesicles
HEK cells are cultured in 8-well coverglass dishes. As they reach 30% conﬂuence, modiﬁed EVs
puriﬁed from eGFP-producing HEK cells are added with a EVs suspension/culture medium
ratio of 1:20. The cells are then incubated 2 days at 37 °C. After detachment from the coverglass,
washing and resuspension in PBS, the cells are analyzed by ﬂow cytometry on a CyAn ADP
high-performance ﬂow cytometer (Beckman Coulter). Fluorescent events are measured by
laser excitation at 488 nm and emission at 510-550 nm.
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4.2.4 Giant unilamellar vesicle (GUV) fabrication
GUVs are produced by electroformation.[304] A solution of lipids in chloroform (1 mgml ) is
transferred into a 5 ml round bottom ﬂask. Chloroform is evaporated ﬁrst with a stream of
nitrogen, then under vacuum for 1-2 h yielding a dry lipid ﬁlm. Single unilamellar vesicles
(SUVs) are produced by adding 1 ml of deionized water to the lipids and sonicating the sample
with a metal-tip sonicator (Vibra-Cell VCX 750 Watts, Sonics) for 5 minutes. 10 μl drops of the
suspension of SUVs are placed onto a ITO-coated conducting glass slide, inside a 1 mm, 250
μl PDMS chamber and dried under vacuum for 2 h. The ﬁlm of lipids is gently rehydrated with
a 200 μM sucrose solution and the chamber is closed with a second ITO-coated glass slide.
Each slide is connected to a current generator electrode applying for 90 minutes an alternating
electrical potential of 1.2 V at 10 Hz to the ITO electrode and subsequently for 30 minutes an
additional alternating potential of 2.5 V at 4 Hz. The chamber is then opened and the GUVs
are carefully collected with a pipette tip with an enlarged diameter and stored at 4 °C.
To prepare GUVs in physiological buffer, the protocol established by Montes et al.[305] was
followed since under these conditions the previous method does not yield a satisfactory
production of vesicles. SUVs suspended in water are carefully deposited on two platinum
wire electrodes of 1 mm diameter placed at 2.5 mm distance sealed in a home-made PTFE
chamber (Figure 4.2). Water is removed by placing the chamber in vacuum for 1 h. Once the
lipids are dried, the chamber is ﬁlled up with physiological buffer and sealed tightly with glass
supported Paraﬁlm M (Bemis North America). Each wire is connected to a power supply. An
alternating voltage of 106 mV at 500 Hz is applied for 5 min, then increased to 940 mV for
20 min and ﬁnally up to 2.61 V for 90 min. The chamber is opened, the GUVs are carefully
collected with a pipette tip with an enlarged diameter and stored at 4 °C.
4.2.5 Controlled opening of GUVs
12μl of a suspension of GUVs are pipetted into the inner well of aμ-Slide Angiogenesis (ibidi).
A circular piece of 20 μm nylon mesh (Millipore) with adapted size is placed on top of the
vesicle sample (Figure 4.5). The top compartment of the well is ﬁlled with the buffer solution
to equilibrate with the GUVs. The stability of the GUVs is monitored over time with a confocal
LSM at the proper excitation/emission wavelengths.
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Figure 4.2: PTFE chamber comprising platinum wire electrodes for the electroformation of
GUVs at high salt concentration.
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4.3 Results and discussion
4.3.1 Cell insertion of EVs carrying genetic material
Based on the observation that geneticmaterial can be transferred from cell to cell via exosomes
and extracellular vesicles, we isolated EVs from HEK cells expressing eGFP to transfect non
ﬂuorescent HEK cells. EVs are produced and isolated as described in section 4.2.1. After
isolation, the presence of EVs in solution is conﬁrmed by ﬂuorescence confocal microscopy,
since the vesicles contain part of the expressed intracellular eGFP. The membrane composition
of EVs is modiﬁed by addition of positively charged lipids according to the protocol described
in section 4.2.2. The lipid-modiﬁed EVs are then added to a cell culture that express no
eGFP and incubated at 37 °C over two days. In parallel, non-modiﬁed EVs are added to
cultured cells as a control. After incubation, the cells have been ﬁrst observed by a confocal
microscopy; the two samples did not show signiﬁcant differences. The cells of the two samples
are therefor analyzed by ﬂow cytometry to provide a statistically relevant amount of single-cell
eGFP expression levels. With this approach, it was possible to detect small, but statistically
signiﬁcant differences of expressed eGFP between the two samples (Figure 4.3).
As expected, the addition of DOTAP in the membrane of EVs increased the ﬂuorescence level
of the analyzed cells as compared to the ﬂuorescence level of control cells stably expressing
the membrane receptor neurokinin 1 receptor (NK1R) fused to eGFP. EVs were modiﬁed
with several concentrations of DOTAP. The isolate of EVs from six 150 ml culture ﬂasks (TPP)
was divided into three equal fractions, completed to 100 ul with PBS, modiﬁed with a ﬁnal
concentration of respectively 0, 0.2 and 0.4 mgml of DOTAP. Lower concentrations were tested
with no signiﬁcant ﬂuorescence increase observed, whereas higher concentrations led to a
high cell death rate. After two-day incubation, the amount of eGFP produced by the infected
cells was maximal. No signiﬁcant increase in ﬂuorescence has been observed after longer
incubation time. The obtained results are in agreement with those reported by Grasso et al.
under different conditions.[202]
4.3.2 Encapsulation of microparticles in GUVs
In a next step, we encapsulated particles with an average diameter of 100 nm in giant unil-
amellar vesicles. As EVs are not stable in water and GUVs are difﬁcult to produce in salt
buffer conditions, we focused ﬁrstly on the encapsulation of ﬂuorescent SUVs, with a diameter
similar to that of EVs, inside GUVs formed in 200 mM sucrose solution. GUVs were electro-
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Figure 4.3: Flow cytometry of HEK cells transfected with DOTAP-EVs containing eGFP RNA.
Normalized ﬂuorescence signals of HEK cells transfected with EVs comprising eGFP mRNA and
different concentrations of DOTAP. In the absence of DOTAP ("EVs only"), only subtle increase of
ﬂuorescence of cellular eGFP is observed. In the presence of 0.2 mgml of DOTAP in the bulk of EVs
suspension, the ﬂuorescence containing cells increased substantially. A further increase of the
DOTAP concentration to 0.4 mgml in the bulk of EVs suspension further increases the number of
cells comprising ﬂuorescence, but has a depleting effect on the survival rate of HEK cells. In pink,
ﬂuorescence unmodiﬁed HEK cells; in green, ﬂuorescence level of HEK cells stably expressing
NK1R-eGFP membrane receptor as a comparative control.
Figure 4.4: Flow cytometry of HEK cells transfected with DDAB-EVs containing eGFP RNA.
Normalized ﬂuorescence signals of HEK cells transfected by EVs containing eGFP mRNA and
different concentrations of DDAB added. No clear increase in ﬂuorescence is observed within
the range of DDAB concentration used for EV modiﬁcation.
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formed according to the protocol of Angelova.[304] SUVs and GUVs were made from a mixture
of 90% POPC, 9% DOPG and 1% of ﬂuorescent lipid, either Liss-Rhod-PE (red) or NBD-PE
(green). Suspension of SUVs was made from 1 mg of lipid mixture dissolved in chloroform,
dried in a 5 ml glass bulb and resuspended in 1 ml of deionized water or 200 mM sucrose
and then vortexed and either tip-sonicated (5 minutes) or extruded (100 nm pore-size ﬁlters,
Miniextruder from Avanti Polar Lipids). The stock preparation of SUVs is diluted at a 1:500
ratio in 200 mM sucrose and used for electroformation of GUVs. If, during the formation of
GUVs, SUVa are present in the surrounding bulk solution, they are ﬁnally in the lumen of
GUVs.
Since we eventually want to observe the release of SUVs, the remaining non-trapped SUVs in
the bulk must be removed from the GUVs. A procedure developed during my master thesis was
used for this purpouse.[306] Twelve μl of GUVs are placed in the bottom of a compartmented
plastic coverglass with a "well-in-a-well" structure (μ-slide Angiogenesis, ibidi) with a mi-
cropipette of which the tip has been cut to a larger diameter. A 20 μm nylon mesh (Millipore),
cut to the exact dimensions to cover the inner well of the μ-slide, is carefully placed on top of
the GUV suspension, while avoiding trapping air bubbles under the mesh. An iso-osmotic
solution to the one in which the GUVs were formed is pipetted on top of the mesh in the
main well. The top and bottom solution will mix reaching, equilibrium in about 30 minutes.
The solution on the top can be easily exchanged by micropipetting without disturbing the
mechanically sensitive GUVs underneath the mesh. After several dialysis operations, the GUV
outer medium is cleaned from SUVs and GUVs containing SUVs can be easily observed (Figure
4.6).
To be noted, the GUV permeabilization protocol developed elsewhere[306] does not allow the
SUVs to pass through the membrane of GUVs as the local destabilized membrane regions are
too small.
4.3.3 Giant vesicle disruption
Release of the GUV content may be initiated by various processes such as pH change, photo-
chemical processes, mechanical stress, acoustic waves, temperature change or addition of
chemicals.[307, 308, 309, 310, 311] In many cases, the content release is mediated by a local
destabilization in the GUV membrane. As we aim to trigger the release of large objects of more
than 100 nm, small defects that let small molecules ﬂow out of the GUVs are not suitable to
meet our objective. We thus focus on methods that are able to completely open or destroy the
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Figure 4.5: Scheme of the systemused for exchanging solution surrounding GUVswithmin-
imal perturbation. The system for buffer exchange is made from a compartmented plastic
coverglass with a "well-in-a-well" structure (μ-slide Angiogenesis, ibidi). Each individual
well contains a smaller well, originally used for a gel matrix supporting cells growing on top.
GUVs are carefully deposited in the inner well, which is then covered by a nylon mesh (in our
case, a 20 μm mesh) that allows passive diffusion between the inner and the top well while
keeping the GUVs protected from mechanical perturbations such as convective stress created by
pipeting liquid in the top well. The liquid of choice can be pipetted safely in the large top well to
create a diffusive ﬂux that will dilute the solution of the inner well into the upper well’s liquid
by a factor of 6-7 in about 30 minutes. This microdialysis procedure can be repeated several
times to formally replace the initial bulk solution surrounding the GUVs by a solution of choice.
Interesting to note is that high ionic strength buffers can be used as exchange solution. However,
a permeabilization procedure is necessary to change the GUV inner liquid as well to avoid
osmotic shock.[306] Image modiﬁed from ibidi μ-slide Angiogenesis description webpage
(http://tinyurl.com/zu76hng).
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Figure 4.6: Green ﬂuorescent GUV comprising red ﬂuorescent SUVs trapped inside are made
of a mixture of 90% POPC, 9% DOPG and 1% of respectively NBD-PE and Liss-Rhod-PE. Non-
trapped SUVs in the outer bulk phase bulk have been removed by repeated microdialysis to
permit the observation of the release of SUVs from the inside of GUVs. Scalebar = 10 μm.
GUVs while keeping the SUV intact. pH-sensitive liposomes have been considered for quite a
long time as potential selective vehicles for therapeutic molecules.[312] Spatial bidimensional
reorganization of lipids according to their charge have the potential to destabilize liposomes,
inducing the collapse of the spherical structure. Methods using detergents are excluded as we
aim to release the GUV content nearby living cells, and ultimately in living organisms while
causing minimum damage. Temperature-sensitive lipids, although extremely interesting for
the release, are very sensitive the most subtle change in experimental conditions, especially
regarding the relative osmolarity of the solutions inside and outside the GUVs, and were not
tested here. The use of chemicals in the surrounding of GUVs is prohibited, unless it does not
harm living cells. A few chemicals fulﬁll this requirement in the tested conditions and may
be candidates for release of EVs. Light-reactive compounds are of interest since they allow a
precise control in space and time of the triggering of photochemical response.
pH-sensitive lipids as destabilizing agents
Growing tumors often show locally decreased pH values.[313] A change in pH can trigger the
release of vesicle cargoes which could be used to release locally therapeutic agents to treat
cancer.[314] In this context, the pH-sensitive lipidDODAP (1,2-dioleoyl-3-dimethylammonium-
propane) is of interest. It is neutral at physiological conditions and protonated at its tertiary
amino group at low pH, forming a positively charged lipid headgroup. The positive charges
destabilize the membrane of the GUVs. By addition of HCl to the surrounding medium, the
GUVs are destabilized and are able to release the enclosed SUVs. Vesicles containing 10%
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Figure 4.7: Fluorescentmicrographs of GUVs composed of 90%POPC, 10%DODAP. The 10%
DODAP-containing vesicles are aggregated at pH 7 and are separated as individuals at pH 3 after
HCl addition. A, time = 0 s; B, time = 20 s; C, time = 450 s after addition of HCl; Liss-Rhod-PE is
used as ﬂuorescent probe; Scalebar = 50 μm.
DODAP are aggregated at pH 7. Addition of 100 mM HCl to reach a ﬁnal pH of 3 separates the
vesicles as individuals, without however breaking them in a noticeable way (Figure 4.7).
An alternative to DODAP is DGS (1,2-dioleoyl-sn-glycero-3-succinate), another pH-sensitive
lipid. Here a carboxylic group is the functional group which can be protonated; therefore DGS
is negatively charged at pH 7 and will become neutral at low pH values, which in turn leads to
fusion and leakage of GUVs.
Diyne-PC containing vesicles
Here we report on experiments to destabilize GUVs by using the photopolymerizable lipid
diyne-PC, used to trigger the release of small molecules from SUVs.[315, 316] The release
of vesicle content relies here on two-dimensional aggregation and polymerization of lipids
containing photoactivatable carbon-carbon triple bonds that crosslink upon illumination
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Figure 4.8: Fluorescent micrographs of GUVs composed of 90% POPC, 10% DGS. A giant
multilamellar vesicle containing DGS undergoes progressive loss of its external lipid bilayers
at pH 3 after addition of HCl. The most external bilayer is pealed away after 3 minutes (B, C),
the second bilayer 25 seconds later (D, E) and the last one after 5 minutes (F, G), releasing the
entrapped lipid aggregates. The graph depicts the ﬂuorescence intensity of the vesicle edges,
showing the progressive loss of the external layers, one by one, in an unwrapping fashion.
A, time = 0 s; B, time = 164 s; C, time = 184 s; D, time = 207 s; E, time = 209 s; F, time = 325 s;
G, time = 336 s after addition of HCl; Liss-Rhod-PE is used as ﬂuorescent probe; Scalebar = 10
μm.
by UV light. Photocrosslinking induces phase transition that permeabilizes the lipid bilayer
and releases the vesicle content. Molar ratios of diyne-PC of 5%, 10% and 15% in vesicles
composed of a 9:1 mixture of POPC:POPG were tested. Under these conditions, we never
observed GUVs. This might result from a destabilizing effect of the diyne-PC partly due to its
length of the carbon chains made of 23 atoms whereas POPC and POPG are shorter with acyl
chains of 18 and 16 carbon atoms. Another destabilizing contribution might arise from the
relative rigidity of the hydrocarbon chains of diyne-PC containing both two carbon-carbon
triple bonds. This rigid rod-like structure contrasts with the highly ﬂexible acyl chains of
surrounding lipids, which are more prone to form a stable two-dimensional ﬂuid bilayer.
Addition of epigallocatechin gallate to the vesicle surrounding buffer
Epigallocatechin gallate is a catechin ester molecule, from the ﬂavonoid family, found in
abundance in green tea extract and exhibiting an antibacterial activity.[317] Epigallocate-
chin gallate interacts with lipid vesicles by progressively reducing their size until it totally
destroys the initial spherical vesicle structure.[318] Epigallocatechin gallate forms holes in
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lipid bilayers[317] which are large enough to enable the release of SUVs from GUVs.
Using the system described in ﬁgure 4.5, we incubated GUVs in solution with epigallocatechin
gallate at a concentration of 700 μM. Since the migration of molecules through de nylon mesh
is limited by diffusion, no effect could be observed on the GUVs during the ﬁrst 15 minutes.
Afterwards vesicles start to decrease in size and irregular, less stable lipidic structures appear
and stick to GUVs. After 20 minutes, GUVs suddenly collapse forming large lipid clumps,
releasing the content of the collapsed GUVs (Figure 4.9). HEK cells survived over several hours
in the presence of a concentration of 1 mM epigallocatechin gallate, indicating a potential in
vivo use.
Photochemical disruption of GUVs using TPPS2a
In the following, we investigated whether TPPS2a encapsulated inside GUVs can be used
for photochemically induce the release of SUVs from the GUVs.[319, 194] Giant vesicles are
electroformed in the presence of both ﬂuorescent SUVs and TPPS2a at high concentration.
The formed GUVs are placed in the microdialysis system to remove non-encapsulated SUVs
while keeping the TPPS2a concentration in the outer medium at 7
μg
ml . PBS is used for the
ﬁnal dialysis step to remove TPPS2a from the solution. The vesicles are observed with a
confocal microscope thanks to 1% ﬂuorescent lipids. Illumination of the vesicles containing
the photosensitizer with a 5 mW laser pointer (405 nm) initiates the photochemical process.
Thereby a part of the GUVs were disrupted remarkably quickly, between 15 seconds and 1.5
minute, releasing their cargo (Figure 4.10). SUVs released from GUVs can be seen in ﬁgure
4.10.H. Yet only a fraction of the total GUVs were found to open upon illumination.
As light can be easily and precisely controlled over time and space, the use of light-triggered
release of EVs fromGUVs appears not only to be themost efﬁcient, but also themost applicable
method among the ones tested for future in vivo tests, since it does not require a high blood
concentration of TPPS2a .
4.3.4 Towards EV liberation from GUV cargos
In the following, we report experiments to transfect HEK cells with SUVs comprising eGFP
plasmids and containing DOTAP. We ﬁrst tried to encapsulate the full length pEGFP-N1 plas-
mid (Clonetech), but neither sonication, nor extrusion of SUVs resulted in detectable eGFP
expression after incubation with cells. We believe it is due to the size of the plasmid, which
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Figure 4.9: Fluorescent GUVs (90% POPC, 9% DOPG, 1% NBD-PE (green ﬂuorescent)) con-
taining SUVs (90% POPC, 9% DOPG, 1% Liss-Rhod-PC (red-ﬂuorescent)) during addition
of epigallocatechin gallate to a ﬁnal concentration of 700 μM. Using the system depicted in
Figure 4.5, vesicles (A) are exposed to epigallocatechin gallate by slow diffusion. The vesicles start
to collapse approximately 1200 seconds after the addition of epigallocatechin gallate. Within
less than a minute, the content of a vesicle is released. Image series taken at 1 frame every
20 seconds. A, time = 77 s; B, time = 1179 s; C, time = 1230 s after addition of epigallocatechin
gallate. B and C have been contrast enhanced to compensate photobleaching caused by laser
excitation of the ﬂuorescent probes. Scale bar = 10 μm.
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Figure 4.10: Green ﬂuorescent GUVs (90% POPC, 10% DOPG, 1% NBD-PE) containing red
ﬂuorescent SUVs (90% POPC, 10% DOPG, 1% Liss-Rhod-PC) and TPPS2a irradiated by UV
light. Green ﬂuorescent GUVs containing red ﬂuorescent SUVs are destroyed photochemically.
The ﬁrst vesicle breaks after 15 s of light irradiation, the second breaks after 45 s. Released SUVs
are visible in H. Images during irradiation exhibit more intense ﬂuorescence because of the
additional excitation light input provided by the illuminating laser. A, B, C, time = 0 s; D, E, F,
time = 15 s; G, H, I, time = 45 s of irradiation. Scale bar = 10 μm.
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might be too large to integrate into SUVs. The plasmid is composed of 4700 base pairs which
might ﬁnally form a compact structure of 500 nm.[320] We then tried smaller DNA fragments
of the plasmid, but obtained no conclusive results.
We ﬁnally focused on a method to encapsulate green ﬂuorescent EVs inside GUVs as de-
scribed in section 4.2.4 using EV-containing solution during GUV formation. It has been
shown that vesicles derived from erythrocyte ghosts did not loose their inner content upon
formation under physiological conditions. After formation, vesicles have been observed, most
of them multilamellar with a low proportion of unilamellar vesicles. No clear evidence of
encapsulated EVs could be found, despite some GUVs displaying a unusually high green
(ﬂuorescent reporter of GUV lipid mixture) to red (eGFP encapsulated in EVs) ﬂuorescence
ratio at the vesicle membrane, suggesting that EVs are fusing with the lipid ﬁlm during the
vesicle electroformation process.
We will now discuss alternative methods that were not tested in this thesis. The method of
Horger et al. [321], designed to make giant vesicles from a lipid ﬁlm deposited on ultra-low
melting agarose in saline buffer, could be a potential candidate, provided EVs can diffuse
through agarose.
Shear-stress sensitive vesicles, made of the artiﬁcial lipid Pad-PC-Pad, may take advantage of
the local pressure created in vivo by a growing tumor to trigger automatically the release of
nano-sized cargoes in the area of interest.[322] Release of microvesicles remains however to
prove possible, since the shear-stress release is suspected to occur via transient pores rather
than vesicle disruption.
Two last methods consist in encapsulating EVs inside larger vesicles in microﬂuidics by forma-
tion of droplets of an EV suspension in a lipophile liquid containing lipids.[323, 324] These
methodologies circumvent the problem of the high ionic strength of physiological media
and insure both homogenous size and unilamellarity. They furthermore ensure a high yield
of encapsulation and are less limited in the choice of the lipids used for making the GUVs.
Replacing the lipophile solvent to make the GUV suspension in vivo-compatible remains a
problem and can be possibly solved by dialysis. Yield, size and encapsulation efﬁciency of the
vesicles are directly proportional to the microﬂuidic parameters, in particular ﬂow rate and
channel dimensions.
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4.4 Conclusion and outlook
There is an ever increasing demand for technological advances in the context of precision
medicine. In this chapter, we explored the possibilities to use extracellular vesicles as nano-
sized cargoes for the delivery of native material into cells. We have shown that if the fusion of
EVs with target cells is inefﬁciently mediated by surface proteins, the addition of the positively
charged lipid DOTAP to the bilayer of EVs make them more prone to release their content into
cells, which have an overall negatively charged plasma membrane. Genetic material enclosed
in EVs can be translocated and subsequently be expressed in the recipient cell to palliate for
example a lack of critical protein for therapeutic purpose. It is important to keep in mind that
the genetic material contained in EVs is mRNA, which has a limited lifetime in cells and can
be translated into proteins only a limited amount of times. Hence it is critical to overload the
EV-producing cells with the desired mRNA sequence to achieve reasonable effect to the target
cells.
We have shown that SUVs, a size and composition equivalent model of EVs, can be encap-
sulated in giant unilamellar vesicles and then released upon various trigger reactions. This
approach could become of interest to efﬁciently deliver biological material, including geneti-
cal material, into diseased cells in a controlled manner. The use of characteristic features of
a disease, such as tissue compression, local low pH, or increased body temperature, could
be considered as trigger factors. Exogenous opening of GUVs induced by light provides a
high spatial and temporal control of releasing the content of GUVs. Interesting possibilities to
release vesicles up to about 1000 nm are: (1) DGS, a pH-sensitive lipid that can be inserted
into the membrane of GUVs. (2) Epigallocatechin gallate, a tea catechin that destroys GUVs
while preserving living cells. (3) TPPS2a , a photosensitizer that destabilizes GUVs from the
inside upon UV illumination.
Using the body’s own cargo system to transport desired molecules or genetic material may
revolutionize the way to administer treatments in speciﬁc areas of the body. Production of EVs
with selected recruitment and fusion proteins in large quantities could provide standardized
man-engineered natural magic bullets, containing genetic material able to be delivered on
demand. Though it is not yet realized in concrete application, targeting medicine offers
interesting possibilities for future medication for curing and healing purposes.
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5 Overall conclusion
Micro-sized devices are gaining increasing importance in many ﬁelds of bioanalysis as they
offer single-cell applications which are difﬁcult or impossible to reach with classical technolo-
gies. Usually, experimental data are obtained from the study of large numbers of cells, whereas
results are represented and interpreted on the basis of consensus average properties of a
single cell. However, increasing experimental evidences on the biochemical and functional
variability between individuals in populations of cells demonstrate that a one-cell prototypical
property does not properly represent a whole cell population. Consequently, to elucidate
a cell’s functional or, in the context of a disease, dysfunctional state, genetic or phenotypic
characteristics of individual cells have to bemeasuredwithin the cell population. Here we have
developed bioanalytical methods for probing the biochemical composition and mechanical
properties of single cells and for delivering compounds into cells.
The single-cell methods developed within this thesis probe various properties of single cells.
The investigations methods presented here are targeting two speciﬁc locations of a cell and
aim at (i) the determination of local viscoelastic properties of a cell’s plasma membrane and
(ii) the quantiﬁcation of intracellular analytes. Both methods yield important information
about the functional state of each observed cell. These novel ways of probing individual cells
are directed to two constitutive aspects of a cell, the plasma membrane and the cytoplasm
content, to harvest information of distinct sources and provide a broader biomedical proﬁle
of a speciﬁc disease if used in combination.
First we have investigated the mechanical properties of human skin melanoma cells origi-
nating from patients at different stages of cancer development. We demonstrated that the
back relaxation of nanotubes of plasma membranes pulled out of cancer cells with the help of
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laser tweezers yields important information of the viscoelastic properties of the cells and are
able to distinguish cancer cells at different stages of tumor development. This opens novel
possibilities in diagnosing the functional state of tumor derived cancer cells.
Further, we developed an alternative concept of chemical cytometry in microﬂuidics em-
ploying micron-sized particles as intracellular probes. Our approach addresses inherent
limitations of present chemical cytometry methods by (i) preventing dilution of target ana-
lytes upon cell lysis, and (ii) by parallelization of the analyte separation step. Here we used
micrometer sized silica beads coated with high-afﬁnity receptors to capture a speciﬁc analyte.
The afﬁnity beads are adsorbed on top of cells, internalized by phagocytosis and then, using
the photosensitizer TPPS2a , the phagosomes were broken upon illumination at a wavelength
of 405 nm to allow direct contact with the components of the cytoplasm. Finally, target an-
alytes were captured by the accessible afﬁnity beads. Cells were then processed through a
microﬂuidic chip where cells containing a bead are captured by an optical trap. The cells were
lysed, and the bead, with target analytes attached to it, were characterized by a speciﬁc marker.
Our method analyzes 1-2 cells per minute with manual operation and could increase greatly
its throughput by automation. Parallel binding of multiple analytes to beads has been shown,
opening the way for very efﬁcient multiple analyte detection with single-cell resolution. In
summary, our bead-based analysis presented here offers interesting novel opportunities for
single-cell analyses in diagnostics and therapy towards personalized medicine. An attractive
future development would be a platform combining the two latter methods. This would
allow to ﬁrst analyze to ﬁrst analyze the viscoelastic properties of the plasma membrane of
a single and subsequently its biochemical content, for example concerning cancer markers.
Such sequential analyses would provide simultaneously critical information about the type of
cancer and its progression state with a single-cell resolution.
Finally, we explored the potential how cell-derived extracellular vesicles could be enclosed
as cargo in giant unilamellar vesicles (GUVs), and, after controlled release, might be used as
cell modifying agents. We ﬁrst showed that EVs enriched on their membrane surface with
positively charged DOTAP lipids were capable to deliver genetic material derived from their
mother cell into a target cell leading to the expression of a particular protein. We then showed
in a separate step that SUVs, a size and composition equivalent model of EVs, could be ﬁrst
enclosed into and then released from giant vesicles using a photochemical trigger. This tool
has the potential to be used within gene therapy as a complementary tool to the previous
methods, regarding the development of a personalized, highly individual speciﬁc biomedical
process of diagnosis and treatment of diseases such as cancer or chronical inﬂammatory
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diseases, which display a high cell-to-cell heterogeneity.
The relevance of the single-cell methodologies developed in the present thesis are becoming
obvious from the following few examples out of many: (i) Cell differentiation in multicellular
organisms is known since the beginning of cell biology; single-cell analysis would discover
differences and heterogeneity of protein proﬁles and their biological relevance between and
within the various cell types, including rare ones such as the different forms of stem cells,
which are of central importance for generation, homeostatic regeneration and repair of tis-
sues. Single-cell analysis will have a big impact to understand stem cell behavior, which is
essential for potential therapeutic applications. (ii) Cellular gene expression is known to occur
stochastically; this leads to massive cell-to-cell variations in the concentration of rare proteins
many of which play an important role in cell functioning and signaling. (iii) Cancer tumors
show enormous variability which is manifested in a large heterogeneity of signaling proﬁles
between individual cells; these variations might be of importance for cancer cell survival
and pathology and a deeper understanding of such processes is of utmost medical relevance.
Consequently, the methods developed in this thesis overcome limitations of presently used
ensemble measurements and might in the future be used in the context of the examples
mentioned before.
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